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Motivation: Contradictory results have been shown in studies measuring the effect of muscle 
fatigue on the level of synchrony between the oscillatory, cortical and muscular electrical 
activities (also known as corticomuscular coupling). In every study, the standard method 
(coherence) used to measure the level of synchrony takes into account both the amplitude and 
phase of the two signals.  However, the use of the phase lock value (PLV) has been overlooked 
as a method for determining the level of synchrony. While the PLV is modulated purely by the 
phase between the two signals, it is unaffected by any amplitude variation. This study aims to 
determine whether amplitude variations in electroencephalography (EEG) and 
electromyography (EMG) could have caused the contradictory results when comparing pre-, 
during and post-fatigue measures of corticomuscular coupling, which consequently affected 
the conclusions drawn regarding the monitoring of fatigue by the central nervous system. A 
determination will be made regarding the contradictions by directly comparing the two 
methods (coherence and PLV) on the same dataset of simultaneously measured EEG and EMG 
signals throughout an isometric pre-, during and post-fatigue task.   
Materials and Methods: Fifteen right-handed, healthy, male participants were tested during 
three stages of palmar abduction: Stage 1, pre-fatigue, was a 10% of maximal voluntary 
contraction (MVC) for 10s repeated 6 times; Stage 2, fatigue, was a 30% of MVC till task failure 
(when the % MVC dropped below 20% for more than 2 seconds); and Stage 3, post-fatigue, was 
a repeat of Stage 1. A 16-channel EEG cap was placed over the head and an 8-channel surface 
EMG electrode grid was placed over the abductor pollicis brevis (APB) muscle. Raw EEG, EMG 
and force signals throughout a voluntary APB muscle contraction pre-, during (which 
encompassed two stages one prior to transition to fatigue [first stage] and one after transition 
to fatigue [second stage]) and post-fatigue were recorded and analysed.  
Results: Results from previous literature were replicated pre- and post-fatigue thereby 
validating the experimental protocol. The coefficient of variance of force significantly increased 
from pre-fatigue to post-fatigue (3.473 ± 2.269 to 7.873 ± 5.568%, p = 0.001), while the 
normalised beta force power spectral density significantly increased from pre-fatigue to post-
fatigue (0.004 ± 0.001 to 0.005 ± 0.001, p = 0.014). The normalised EMG root mean squared 
significantly increased from pre-fatigue to post-fatigue (0.037 ± 0.022 to 0.051 ± 0.033, p = 
0.017) while the EMG mean power frequency significantly decreased from pre-fatigue to post-
fatigue (100.589 ± 17.366 to 86.948 ± 19.814Hz, p = 0.001). The normalised beta EEG root 
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mean squared significantly increased from pre-fatigue to post-fatigue (0.043 ± 0.017 to 0.048 ± 
0.021, p = 0.025). 
Novel results that appear to also resolve contradictions in the literature relating to the 
corticomuscular coupling methods, PLV and coherence, were observed pre-, during and post-
fatigue. The beta EEG-EMG coherence peak amplitude significantly increased from pre-fatigue 
to post-fatigue (0.023 ± 0.007 to 0.034 ± 0.017, p = 0.008), and the beta EEG-EMG PLV peak 
amplitude also significantly increased from pre-fatigue to post-fatigue (0.102 ± 0.014 to 0.125 ± 
0.029, p = 0.011).  
However, due to amplitude co-variations during the fatigue stage, it was observed that the 
EEG-EMG coherence significantly decreased from the first part to the second part of the fatigue 
stage (0.059 ± 0016 to 0.042 ± 0.017, p = 0.001), whilst the EEG-EMG PLV did not (0.16 ± 0.04 
vs. 0.154 ± 0.039, p = 1.000).  
Conclusion: This study provides evidence that the corticomuscular phase coupling in the beta 
band between the sensorimotor cortex and the APB muscle increases significantly, without the 
confounding effect of the EEG and EMG amplitude, after muscle fatigue occurs during a 
sustained isometric submaximal contraction. These findings suggest that the amplitude co-
variations from the EEG in the sensorimotor cortex and the EMG in the APB muscle support the 
previously published conclusions regarding the central nervous system monitoring pre- and 
post-fatigue. However, during an actual fatiguing contraction, as a result of the confounding 
effect of amplitude, the coherence and PLV measures of the corticomuscular coupling provide 
different results. In such experiments, PLV provides a more reliable measure, resulting in a 
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The general field of interest of the present study is on the level of synchrony between the 
oscillatory cortical and muscular electrical activities. This synchrony is commonly known as 
corticomuscular coherence or corticomuscular coupling (the preferred term used in the present 
study). By measuring the corticomuscular coupling, one can gain insight into the level of 
monitoring of a muscle by the central nervous system. However, current fatigue studies 
provide contradictory results for the level of corticomuscular coupling. Understanding the 
methods of determining levels of corticomuscular coupling will provide insight into the 
physiology of muscular fatigue and could potentially resolve contradictory results in the current 
studies. 
1.1 Motivation 
Fatigue is defined as ‘both physical and mental exhaustion due to prolonged stimulation or 
exertion’. There are two types of physiological fatigue: peripheral and central. Peripheral 
fatigue is a metabolite-induced failure of the contractile function of the skeletal muscle, while 
central fatigue refers to the reduced activation of a skeletal muscle by efferent output from the 
motor cortex of the central nervous system (Noakes & St Clair Gibson, 2004). 
While the origin of muscle fatigue is still in dispute, there are two main streams of thought. The 
more popular belief is that muscle fatigue, which occurs during most forms of exercise, is due 
to a peripheral fatigue and independent of central fatigue. Alternatively, as proposed by 
Noakes and St Clair Gibson (2004), ‘fatigue in any form of exercise may form part of a regulated 
anticipatory response co-ordinated in the subconscious brain, the ultimate goal of which is to 
preserve homeostasis in all physiological systems during exercise’ . 
Interestingly, studies have found increasing evidence suggesting contributions from both the 
central and peripheral systems. Early studies identified muscle fatigue using electromyography 
(EMG) measures alone (González-Izal et al., 2003; Kumar et al., 2003), however, further 
development involved the addition of electroencephalography (EEG) recordings during muscle 
fatigue. For example, Abdul-latif et al. (2004) observed an increase in beta (15-35 Hz) EEG 
activity post-fatigue in the contra-lateral motor cortex. Similarly, van Duinen, et al. (2007) 
showed that activity in the cerebellum, pre-supplementary motor area and frontal area 
increased during fatigue. 
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Current studies use EEG and EMG recordings to determine the corticomuscular coupling during 
fatigue, which is typically calculated using EEG-EMG coherence (Ushiyama et al., 2011; Yang et 
al., 2009). However, these studies provide contradictory results.  
One significant method for determining the level of corticomuscular coupling, the use of the 
phase lock value (PLV), has been overlooked. The PLV is modulated purely by the phase 
between the two signals and is unaffected by any amplitude variation (Lachaux, et al., 1999; 
Srinath & Ray, 2014). This is of particular importance in fatigue studies, because both the EMG 
and EEG amplitudes are known to change during fatigue (Yang et al., 2009; Ushiyama et al., 
2011). 
Therefore, the focus of this study is to investigate if the changes in the EEG and EMG amplitude 
confound the measures of corticomuscular coupling using coherence, thereby affecting the 
conclusions regarding the central nervous system’s monitoring of muscular fatigue. 
1.2 Literature Review 
Section 1.2 describes the literature directly related to the present study.  
1.2.1 Muscle fatigue 
Muscle fatigue is typically quantified as the inability to sustain or reach a set level of maximal 
voluntary contraction (MVC) due to the nature of both the skeletal muscle tissue (peripheral 
fatigue) and the neuromuscular junction (central fatigue) (Gandevia, 2001; Enoka & Duchateau, 
2008) .  
Peripheral fatigue is related to the impairment of the muscle contraction, due the reduction of 
the metabolites and blood supply in the contracting muscle. While, central fatigue is related to 
a reduction in the nerve-based motor command to the muscle (Gandevia, 2001; Enoka & 
Duchateau, 2008).  
The contributions of central and peripheral fatigue during muscle fatigue are still in dispute. 
The more popular model, known as the anaerobic/catastrophe/limitations model, suggests that 
fatigue is caused by a variety of cellular effects, which can alter muscle force production (Weir 
et al., 2006). While, Noakes et al. (2005) suggested that a central governing model manages 
muscle fatigue in order to preserve homeostasis in all physiological systems during exercise. 
However, other studies suggest that when muscle fatigue occurs, it contains both central and 
peripheral components and is possibly task-dependent (Gandevia, 2001; Weir et al., 2006). 
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1.2.2 Muscle fatigue influence on force, EMG and EEG 
Multiple studies have shown that muscle fatigue has an influence on force, EMG and EEG 
measures. These influences are explored in Section 1.2.2. 
1.2.2.1 Muscle force changes due to muscle fatigue 
As mentioned in Section 1.2.1 fatigue is usually quantified by the inability to sustain a set level 
force, however determining a fixed point of when a muscle cannot sustain a force is a difficult 
task and varies from study to study. Also, it has been argued that manifestation of fatigue 
doesn’t instantaneously occur but rather develops over time (Roberto Merletti & Parker, 2004). 
Nonetheless, there is a generally accepted protocol to fatigue a participant for a sustained 
contraction: 
1. The participant’s MVC is measured (usually with a force transducer).  
2. After the participant is given sufficient time to rest their muscle, he/she is required to 
maintain a submaximal isometric contraction (usually below 50% of MVC).  
3. Once the %MVC has dropped by more than 10% for a set time, the participant’s muscle 
was considered fatigued. This set time varies between 2-5 seconds. 
Accordingly it is generally accepted that fatigue has occurred once a participant cannot sustain 
a targeted %MVC for a set amount time (Yang et al., 2009; Kattla and Lowery, 2010; Ushiyama 
et al., 2011). 
Yang et al. (2009) and Ushiyama et al. (2011) also observed that the force generated by the 
muscle becomes less steady during a fatiguing contraction. This was estimated by calculating 
the coefficient of variance of force (forceCV, i.e. the higher the forceCV, the less steady the 
force). Ushiyama et al. (2011) further observed that force within the beta (1535 Hz) band 
(beta forcePSD) significantly increased after the onset of fatigue suggesting that the 
sensorimotor cortex reinforces the rhythmic grouped discharges in the EMG within the beta 
band possibly in an attempt to maintain a stable force output. 
1.2.2.2 EMG changes due to muscle fatigue 
Two well established EMG indices have been used to evaluate central fatigue during an 
isometric contraction. These indices can be calculated by measuring electric potentials of the 
muscle and observing the changes in the amplitude and frequency; such as the EMG root mean 
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squared, EMGRMS and the EMG mean power frequency, EMGMPF, respectively (Viitasalo & Komi, 
1977; De Luca, 1983; Bigland-Ritchie & Woods, 1984). 
Multiple studies have shown a significant increase in the EMGRMS during a fatiguing contraction 
(Viitasalo & Komi, 1977; De Luca, 1983; Arendt-Nielsen et al., 1989; Esposito et al., 1998). This 
increase in EMGRMS would be due to recruitment of additional motor units and/or an increase 
in motor unit firing frequency (Arendt-Nielsen et al., 1989; Dimitrova & Dimitrov, 2003).  
During a fatigued isometric contraction, the EMGMPF has been shown to shift to lower 
frequencies in both other muscles (De Luca, 1983; Bigland-Ritchie & Woods, 1984; Merletti et 
al., 1984; Esposito et al., 1998; Georgakis et al., 2003) and the abductor pollicis brevis (APB) 
muscle (Barandun et al., 2009). A decrease in EMGMPF is compatible with a decrease in the firing 
rate of motor units.  However, even though the EMG is associated with the central drive to the 
muscle, it has been argued that a decrease in the EMGMPF could rather be linked to a decrease 
in conduction velocity and/or change of shape of the motor unit action potentials, therefore 
indicating mechanisms of peripheral fatigue (Eberstein & Beattie, 1985; Moritani et al., 1986; 
Arendt-Nielsen et al., 1989; Merletti & Lo Conte, 1997; Schillings et al., 2003). Therefore a 
decrease in EMGMPF could be a measure of central and/or peripheral fatigue.  
1.2.2.3 EEG change due to muscle fatigue 
EEG measures have been observed to also change due to central fatigue. Liu et al. (2003) and 
van Duinen et al. (2007) observed an increase in brain activation levels as fatigue sets in. More 
specifically, Abdul-latif et al. (2004) observed an increase in the beta (1535 Hz) EEG root mean 
squared (beta EEGRMS; i.e. an amplitude measure in the contra-lateral motor cortex (specifically 
C3 and FC3; see Figure 2-9) after exercise-induced fatigue of the adductor pollicis muscle. This 
suggests that the motor cortex needs an increased descending command to recruit new motor 
units and/or increase the motor unit firing rate within the contracting muscle to compensate 
for the force reduction (Liu et al., 2003 ; van Duinen et al., 2007). 
1.2.3 Corticomuscular coupling measures and muscle fatigue 
Recent studies have implemented a measure of the synchrony between oscillatory cortical 
(usually measured using EEG) and muscular (usually measured using EMG) electrical activities in 
order to provide insight into central muscle fatigue (Tecchio et al., 2006; Ushiyama et al., 2011; 
Yang et al., 2009, 2010). This synchrony is known as corticomuscular coupling. 
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Additionally, corticomuscular coupling has been demonstrated to be a useful parameter in the 
central (i.e. the brain) assessment of the state of peripheral muscular contraction (Baker, 
2007). According to Gwin & Ferris (2012), the corticomuscular coupling’s phase lags are 
consistent with the conduction time between the motor cortex and the respective muscle. This 
is suggestive of a central-peripheral feedback loop. Consistent with this is the suggestion that 
the oscillations in the motor cortex originating in the beta-band (which are similar to the 
oscillations in the activity of contralateral contracting muscles) not only engage motor 
structures, but also sensory feedback from the muscle to the central nervous system via 
feedback afferent pathways, as shown in Figure 1-1 (Baker, 2007). Thus beta corticomuscular 
coupling is a useful measure in determining the relationship between the muscle and motor 
cortex during muscle fatigue. 
Additionally, gamma band (3550 Hz) corticomuscular coupling has been observed during 
strong (Brown, 2000) and dynamic contractions (Omlor et al. ,2007). 
 
Figure 1-1: Pathways which could mediate corticomuscular coupling (Descending (red) and 
ascending (blue).  The figure was adopted from Baker (2007). 
1.2.3.1 Coherence 
The standard measure of corticomuscular coupling is coherence. Coherence, by definition, is a 
spectral measurement of two signals x(t) and y(t calculated from the cross-spectral density 
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between the two waveforms and normalised by the power spectral density of each waveform. 












where 𝑋𝑖(𝑓) and 𝑌𝑖(𝑓) are the Fourier transforms of the signals x and y for the 𝑖th data 
segment at frequency f, and * indicates the complex conjugate. Coherence values range from 0 
(if the signals are incoherent) to 1 (if the signals are perfectly coherent).  
EEG-EMG coherence, therefore, is the coherence between field potentials generated by the 
brain measured using EEG techniques and the muscle measured using EMG techniques. A 
typical EEG-EMG coherence graph is shown in Figure 1-2. 
 
Figure 1-2: Typical EEG-EMG coherence spectrum for an isometric contraction task, adapted 
from Ushiyama et al. (2011). Coherence is considered significant if it falls above the confidence 
limit (CL).  FP (known as EEG-EMG coherencePEAK FREQ in the present study) is the frequency at 
which coherence is at its peak indicated as Cohmax (known as EEG-EMG coherencePEAK AMP in 
the present study). F1 and F2 are the frequency points where coherence intersects with the 
confidence limit. Coharea is the area of coherence between F1 and F2.   
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1.2.3.1.1 Corticomuscular coupling research investigating muscle fatigue 
The following section highlights literature from four studies that analyse the effect of muscle 
fatigue on corticomuscular coupling using EEG-EMG coherence. The results are summarised in 
Table 1-1.  
Tecchio et al. (2006) investigated isometric contractions of the extensor communis digitorum 
muscle. The magnetoencephalography (MEG)-EMG coherence was compared pre- and post-
fatigue. During the pre-fatigue stage, the participant maintains a force at 2035% of MVC for 
20 seconds and rests for 20 seconds thereafter. This exercise was repeated for 5 minutes. 
During the fatigue stage, the participant maintained MVC for as long as possible. The post-
fatigue stage followed 210 minutes after the fatigue stage and was a repetition of actions 
during the pre-fatigue stage. When compared with the pre-fatigue stage, the MEG-EMG 
coherence in the beta band (1535 Hz) increased significantly in the post-fatigue stage (see 
Figure 1-3).  
 
Figure 1-3: Tecchio et al.’s (2006) pre-fatigue (blue), fatigue (green and red) and post-fatigue 
(yellow) stages. The red arrow represents the two stages which were compared. This figure was 








Pre-Fatigue Stage Post-Fatigue Stage 
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Following this, Yang et al. (2009) also quantified EEG-EMG coherence, but now at the beginning 
and end of a fatiguing contraction. Their experiments involved sustaining an isometric elbow 
flexion at 30% of MVC until the percentage of MVC dropped below 20% for longer than 3 
seconds. The fatigue stage was consequently broken into two stages: minimal and severe 
fatigue (as shown in Figure 1-4). The EEG-EMG coherence decreased significantly in the severe 







Figure 1-4: Yang et al.’s (2009) minimal fatigue (green block) stage was represented by the first 
half of the isometric fatiguing contraction, while the severe fatigue stage (red block) was 
represented by the second half. The green arrow represents the two stages that were 
compared. This figure was adopted and edited from Kattla and Lowery (2010). Compare this to 







Yang et al. (2010) on noting that the progressive nature of fatigue cannot be studied by simply 
comparing corticomuscular coupling pre- and post-fatigue or between two long-duration time 
blocks within a fatiguing contraction, proposed to address this issue by investigating the 
wavelet EEG-EMG coherence during the fatiguing stage with two or more sequential blocks (as 
shown in Figure 1-5).  The experiment involved participants performing 200 maximal 
intermitted handgrip contractions in a single fatigue stage. Each trial was 2 seconds long, and 
the wavelet EEG-EMG coherence was completed. 
The fatigue stage was broken into two-, five- and 10-blocks (see Figure 1-5) with wavelet EEG-
EMG coherence measures generated for each block. For the 10-block fatigue stage, the wavelet 
EEG-EMG coherence measures in the beta band (1535 Hz) showed an increase from the first 
to the fifth block followed by a decrease to the tenth block. Although using 10-blocks provided 
a more detailed time course of the coherence alteration, it lacked statistical significance.  For 
the corresponding two-block fatigue stage grouping (similar to Figure 1-4), there however was 
a significant decrease between the wavelet EEG-EMG coherence from the first block to the 
second block i.e. identical results to their previous results (Yang et al, 2009).  
 
Figure 1-5: The wavelet EEG-EMG coherence in the beta band during the fatigue stage was 
separated into 10 blocks. A general increase from the first block to the fifth block and then a 





Ushiyama et al. (2011) then presented a fatigue study of the tibialis anterior muscle in an 
attempt to explain the contradictory results found in the three previous studies (Tecchio et al., 
2006; Yang et al., 2009; Yang et al., 2010) using a muscle shown to provide greater EEG-EMG 
coherence among various upper and lower limb muscles (Ushiyama et al., 2010). This study 
required three stages of movements:  
1. pre-fatigue: dorsiflex the foot for 60 seconds at 30% of MVC; 
2. fatigue: rest for 60 seconds, then dorsiflex the foot at 50% of MVC until force dropped 
below 40% of MVC for longer than 5 seconds;  
3. post-fatigue: no rest, dorsiflex the foot again for 60 seconds at 30% of MVC.  
Ushiyama et al. (2011) then observed similar result as Tecchio et al. (2006) which was an 
increase in EEG-EMG coherence from pre-fatigue to post-fatigue. The study also observed an 
increase during the fatigue stage, although significance was not observed for the fatigue stage.  
Ushiyama et al. (2011) suggested that differences between their study and Yang et al. (2009) 
study, was that Yang et al. (2009) recorded from biceps brachii, brachioradialis and triceps but  
not brachialis, which is the major agonist muscle for elbow flexion. Thus compensatory 
brachialis activities that may have been induced (see Table 1-1) were not accounted for by Yang 
et al. (2009) after muscle fatigue developed. Ushiyama et al. (2011) further suggested that 
differences between their study and Yang et al. (2010) study, was that the respective study did 
a repetitive dynamic contraction which commonly associated with peripheral fatigue compared 
to isometric contraction which commonly associated with central fatigue (Søgaard et al, 2006). 
 
Figure 1-6: Ushiyama et al.’s (2011) pre-fatigue stage (blue block), fatigue stage (green and red 
block) and post-fatigue stage (yellow block) . The red arrow represents the two stages that 














A summary of the studies mentioned is shown in Table 1-1. 
Table 1-1: Summary of studies, investigating the effect muscle fatigue has on corticomuscular 
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Figure 1-7: The stages represented by the colour blocks of the experimental procedure in Table 
1-1. This figure was adopted and edited from Kattla and Lowery (2010). 
  





From the literature summary of Table 1-1, it can be noted that the EEG (aside from Tecchio et 
al, 2006) and EMG amplitude varies significantly with the effect of fatigue. As a result it is 
possible that using coherence to measure the level of corticomuscular coupling could provide 
misleading results for the phase synchrony between the EMG and EEG, as prior literature 
(Srinath & Ray, 2014) demonstrated that coherence is dependent on both phase and 
amplitude. Thus the use of phase lock value (PLV) had been proposed to single out the role of 
phase consistency (Lachaux et al., 1999; Srinath & Ray, 2014) and exclude the effect of 
amplitude. However PLV has not been previously implemented in a muscle fatigue study where 
changes in amplitude occur. 
In addition the studies (i.e. Table 1-1) differed in the muscles as well as the in the stages of 
fatigue that were investigated.   
1.2.3.2 Phase lock value (PLV) 
PLV is a measure of phase synchrony between two signals commonly used in EEG studies 
instead of coherence, since coherence is influenced by amplitude co-variations (Lachaux et al., 
1999; Srinath & Ray, 2014). PLV, also known as phase coherence, ‘is a measure of phase 
consistency of phase differences between electrodes across trials. This is calculated by forcing 
the amplitudes of the signals at frequency to 1, so as to remove any effects of co-variations in 
amplitude’ (Srinath & Ray, 2014).  See Appendix A for a comparison between coherence and 
PLV using simulated data generated by the author and sampled data from Divekar and John 
(2012).  










where 𝜃(𝑡, 𝑖) = 𝜑𝑋(𝑡, 𝑖) − 𝜑𝑌(𝑡, 𝑖) is the phase difference between the two signals at time t in 
the 𝑖th segment/trial. PLV ranges from 0 (no synchronisation) to 1 (perfect synchronisation). 
EEG-EMG PLV would therefore represent the phase relationship between field potentials 




1.2.3.3 EMG Electrode location could influence corticomuscular coupling measures 
Masuda et al. (1999) observed that the EMG electrode location, relative to the muscle 
innervation zone (IZ), could influence the spectral estimates. For the Abductor Pollicis Brevis 
(APB) muscle, Keenan et al. (2012) observed that the electrode pair furthest from the IZ 
provided a greater EMG-EMG coherence amplitude peak. Thus to remove the effect of 
electrode location the IZ should first be detected and avoided. This would require the use of a 
linear electrode array (i.e. a linear adjacent series of bipolar electrodes) instead of a single 
bipolar electrode set. 
The method used by Keenan et al. (2012) to identify the IZ was shown in Figure 1-8. The EMG 
bipolar differences between the series of adjacent electrodes were used to identify the IZ. The 
IZ was then identified as the mid-point of the closest two EMG signals with motor unit action 
potentials propagating in opposite directions i.e. where a clear change in the polarity of the 
phases of the potential was present.   
 
Figure 1-8: Explanation of Keenan et al.’s (2012) method of identifying the IZ for the APB 
muscle: a) a linear EMG array with 16 electrodes was placed over the APB muscle. b) this 
resulted in 15 sequential bipolar signals (i.e. between adjacent electrodes). The IZ was then 
estimated as the location of the interpolated EMG signal that would be closest to the location 
where motor unit action potentials started to propagate in both directions i.e. a clear change in 
the polarity of the phases of the potential was present (identified with an asterisk, *). The 
dashed line is provided as reference to identify the propagation of the muscle fibre action 






1.2.3.4 EEG Electrode location could influence corticomuscular coupling measures  
It has long been established that the sensorimotor region of the brain is involved with muscle 
movements. The greatest change in corticomuscular coupling during fatigue studies was 
observed in the contra-lateral sensorimotor regions (Tecchio et al., 2006; Ushiyama, et al., 
2011; Yang et al., 2009; Yang et al.,2010). 
This is also true for the execution of complex finger movements (Shibasakiet et al, 1993).  
1.2.3.5 Transition point during the fatigue stage 
Measuring the corticomuscular coupling between two, five or 10 blocks (see Yang et al.’s, 2010 
study in Section 1.2.3.1.1) during the fatigue stage can be misleading as the onset of fatigue 
could differ amongst participants (Al-Mulla and Sepulveda ,2010).  
Additionally, Srinath and Ray (2014) observed that coherence and phase lock value measures 
are sensitive to the number of trials. Since the time span of the fatigue stage varies amongst 
participants, the number of trials for the corticomuscular coupling measures will vary. Thus, 
separating the fatigue stage into two, five or 10 blocks, could result in a misleading conclusion.  
 Al-Mulla and Sepulveda (2010) therefore suggested a method of identifying the time point of 
transition to fatigue using the EMG total band power (EMGPOWER) and EMG median frequency 
(EMGMDF). EMGMDF is subtracted from EMGPOWER to calculate the output ‘1D spectro’ (see Figure 
1-9). The transition to fatigue point is then found when 1D spectro increases (see Figure 2-15). 
Therefore observing parameters (such as corticomuscular coupling measures) before and after 




Figure 1-9: 1D spectro is calculated by subtracting EMGMDF from EMGPOWER. This figure was 
adopted from Al-Mulla and Sepulveda (2010). 
1.2.4 Summary 
Corticomuscular coupling using coherence has been observed to both increase (Ushiyama et 
al., 2011) and decrease (Yang et al., 2009) significantly in the beta band due to fatigue. Both 
studies also showed a change in EEG and EMG amplitude due to fatigue. In a non-fatigue study, 
PLV has been recommended over coherence by Srinath and Ray (2014). This is because the 
change in coherence between EEG and EMG can be evaluated as a change in amplitude, phase 
shift or both. Therefore, to single out the role of phase consistency in corticomuscular coupling, 
a PLV analysis would be preferable. 
1.3 Hypothesis 
The hypothesis of the study is that the EEG-EMG PLV would provide a more accurate measure 
of EEG-EMG phase coupling than EEG-EMG coherence, which is confounded by amplitude 
variation. Hence the novel use of EEG-EMG PLV in muscular fatigue studies may resolve 




The main aim of the present study is to investigate if the corresponding EMG and EEG 
amplitude changes confound coherence measures pre-, during and post-fatigue measures of 
corticomuscular coupling by comparison to PLV measures. This may ultimately influence the 
physiological conclusions regarding central nervous system monitoring of muscular fatigue. 
1.5 Sub aims and corresponding experimental outcome variables  
Sub aims and objectives were derived. The objectives related to force, EMG, EEG and the 
corticomuscular coupling, which were measured pre-, during and post-fatigue. The objectives 
were then grouped according to sub aims, and each objective is listed below with the actual 
variable names given in brackets. 
1.5.1 Sub Aim 1: Carry out an experimental protocol which predominantly gives rise 
to central fatigue (hence the corresponding outcome measures listed below) 
1. Raw electromyography (EMGRAW) 
2. Raw electroencephalography  (EEGRAW) 
3. Force as % of maximal voluntary contraction (%MVC)  
4. Electromyography power spectral density (EMGPSD) 
5. Electroencephalography power spectral density (EEGPSD) 
6. Force as % of maximal voluntary contraction power spectral density (forcePSD) 
1.5.2 Sub Aim 2: Determine the influence muscle fatigue has on force, EMG and EEG 
(hence the corresponding outcome measures listed below) 
1. Co-efficient of variance of force (forceCV) 
2. Normalised beta force as % of maximal voluntary contraction power spectral density 
(beta forcePSD) 
3. Electromyography root mean squared (EMGRMS) 
4. Electromyography mean power frequency (EMGMPF) 
5. Beta electroencephalography root mean squared (beta EEGRMS) 
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1.5.3 Sub Aim 3: Determine corticomuscular coupling as measured by EEG-EMG 
coherence (with EMG and EEG amplitude confounds) compared to EEG-EMG 
PLV (no amplitude confounds) (hence the corresponding outcome measures 
listed below) 
1. Electroencephalography channel selected (EEGSELECT) 
2. Electromyography channel selected (EMGSELECT) 
3. Electromyography band power (EMGPOWER) 
4. Electromyography median frequency  (EMGMDF) 
5. 1D spectro  (1DSPECTRO) 
6. Beta electroencephalographyelectromyography coherence peak amplitude (beta EEG-
EMG coherencePEAK AMP), pre- and post-fatigue 
7. Beta electroencephalographyelectromyography coherence peak frequency (beta EEG-
EMG coherencePEAK FREQ), pre- and post-fatigue 
8. Beta electroencephalographyelectromyography phase lock value peak amplitude 
(beta EEG-EMG PLVPEAK AMP), pre- and post-fatigue 
9. Beta electroencephalographyelectromyography phase lock value peak frequency 
(beta EEG-EMG PLVPEAK FREQ), pre- and post-fatigue 
10. Beta electromyography root mean squared (beta EMGRMS) before and after transition 
to fatigue (first and second part of the fatigue stage) 
11. Beta electroencephalography root mean squared (beta EEGRMS) before and after 
transition to fatigue (first and second part of the fatigue stage) 
12. Beta electroencephalographyelectromyography coherence peak amplitude (beta EEG-
EMG coherencePEAK AMP), before and after transition to fatigue (first and second part of 
the fatigue stage) 
13. Beta electroencephalographyelectromyography phase lock value peak amplitude 
(beta EEG-EMG PLVPEAK AMP), before and after transition to fatigue (first and second part 





1.6 Scope of the study 
The present study is a pilot with 15 right-handed human participants, using EEG and EMG 
measurement techniques. Only neurologically-normal, healthy participants were used in this 
study. Fatigue was assumed if the participant could not hold 10% below a targeted %MVC for 
longer than 2 seconds. The muscle analysed was limited to the APB muscle (see section 
2.1.1.2).  
1.7 Plan of development 
Section 2 (METHODOLOGY) describes the participants, experimental protocol, data recording, 
data analysis and statistical analysis carried out to test objectives of the present study. 
Section 3 (RESULTS) contains the results of the comparisons of the variables (listed under the 
objectives) between pre- and post-fatigue in both qualitative and quantitative form. 
Section 4 (DISCUSSION) discusses the results obtained and explores possible reasons for the 
outcomes.  




A detailed view of methodology and results for each sub aim in Section 1.5 is provided in Figure 1-10. 
 
1.4 Aim: Do EMG and EEG amplitude changes confound pre- and post-fatigue measures of corticomuscular coupling, thereby affecting conclusions 
regarding central nervous system monitoring of muscular fatigue. A pilot study using the APB muscle
1.5.1 Sub Aim 1: Carry out an experimental 
protocol which predominantly gives rise to 
central fatigue.
2.1 Methods:
1. Carry out test procedure ,recording  and 
logging of force, EMG and EEG required 
for analysis









1. Show raw and PSD EMG, EEG and force 
pre- and post-fatigue






1.1 Perform Force CV 
1.2 Perform normalised beta PSD force 
2.1 Perform EMG RMS
2.2 Perform EMG MNF
3.1 Perform beta EEG RMS 
2.2.6 STATS:
1.1 Perform Force CV pre- and post-fatigue
1.2 Perform normalised beta PSD force pre- and post-
fatigue
2.1 Perform normalised EMG RMS pre- and post-fatigue
2.2 Perform EMG MNF pre- and post-fatigue
3.1 Perform normalised beta EEG RMS pre- and post-
fatigue
3.1.2 Results:
1.1 Show Force CV 
1.2 Show normalised beta PSD force 
2.1 Show EMG RMS
2.2 Show EMG MNF
3.1 Show beta EEG RMS 
3.2.1 STATS:
1.1 Show Force CV pre- and post-fatigue
1.2 Show Normalised beta PSD force pre- and post-
fatigue
2.1 Show Normalised EMG RMS pre- and post-fatigue
2.2 Show EMG MNF pre- and post-fatigue
3.1 Show Normalised beta EEG RMS pre- and post-fatigue
1.5.3. Sub Aim 3: Carry out EMG-EEG phase relationships as measured by EEG-EMG coherence 
(with EMG and EEG amplitude confounds) vs EEG-EMG PLV (no amplitude confounds)
2.3 Method:
1. Find EMG channel by finding IZ 
2. Find EEG channel by finding with peak EEG-EMG coherence and EEG-EMG PLV using a 
topographic plot.
3. Find transition to fatigue point 
4. Perform beta EEG and EMG RMS  before and after transition to fatigue 
5. Perform beta EEG-EMG coherence peak amplitude, frequency  pre- and post-fatigue 
6. Perform beta EEG-EMG PLV peak amplitude, frequency in pre- and post-fatigue
7.    Perform beta EEG-EMG coherence peak amplitude, before and after transition to fatigue 
8. Perform beta EEG-EMG PLV peak amplitude before and after transition to fatigue 
 
2.3.6,7 STATS:
1. Perform beta EEG and EMG RMS  before and after transition to fatigue  
2. Perform beta EEG-EMG coherence pre-, post-fatigue, before and after transition to fatigue 
point 
3. Perform beta EEG-EMG PLV  pre-, post-fatigue, before and after transition to fatigue point
3.1.3 Results:
1. Raw EMG from each channel to indicate IZ
2. Verify EEG channel choice by using topographic view
3. Show 1D spectro
4. Show beta EEG and EMG RMS  before and after transition to fatigue  
5. Show beta EEG-EMG coherence pre- and post-fatigue
6. Show beta EEG-EMG PLV pre- and post-fatigue
7. Show beta EEG-EMG coherence before and after transition to fatigue 
8. Show beta EEG-EMG PLV before and after transition to fatigue 
 
3.2.2,3 STATS:
1. Show beta EEG and EMG RMS  before and after transition to fatigue  
2. Show beta EEG-EMG coherence pre-, post-fatigue, before and after transition to fatigue 
point 
3. Show beta EEG-EMG PLV  pre-, post-fatigue, before and after transition to fatigue point
Objectives:
1. Determine EMG channel selected for corticomuscular coupling measures
2. Determine EEG channel selected for corticomuscular coupling measures
3. Determine transition to fatigue using 1D spectro
4.    Determine beta EEG and EMG RMS  before and after transition to fatigue 
5. Determine beta EEG-EMG coherence peak amplitude, frequency pre- and post-fatigue 
6. Determine beta EEG-EMG PLV peak amplitude, frequency in pre- and post-fatigue
7.    Determine beta EEG-EMG coherence peak amplitude, before and after transition to fatigue 
8. Determine beta EEG-EMG PLV peak amplitude before and after transition to fatigue 
Determine Statistically:
1. Determine beta EEG and EMG RMS  before and after transition to fatigue  
2. Determine beta EEG-EMG coherence pre-, post-fatigue, before and after transition to 
fatigue point 
3. Determine beta EEG-EMG PLV  pre-, post-fatigue, before and after transition to fatigue point
Objectives:
1.1 Determine force CV 
1.2 Determine normalised beta PSD force 
2.1 Determine EMG RMS
2.2 Determine EMG MNF
3.1 Determine beta EEG RMS 
Determine Statistically:
1.1 Determine force CV pre- and post-fatigue
1.2 Determine normalised beta PSD force pre- and post-
fatigue
2.1 Determine normalised EMG RMS pre- and post-
fatigue
2.2 Determine EMG MNF pre- and post-fatigue
3.1 Determine normalised beta EEG RMS pre- and post-
fatigue
Objectives:
1. Determine raw and PSD EMG, EEG and 
force pre-and post- fatigue
 








Section 2 describes the methodology corresponding to the objectives mentioned in Section 1.5. 
2.1 Experimental protocol methodology 
Section 2.1 deals with the how the experiment was carried out and how signals for force, EMG 
and EEG were acquired during the experiment.  
2.1.1 Criteria for experimental protocol 
The present study follows on the theory purposed by Weir et al. (2006) that, during muscle 
fatigue, the contributions of central and peripheral fatigue are task-dependent; therefore, an 
appropriate experimental protocol was derived. 
Section 1.2.2 describes:  
 Types of contraction 
 Selection procedure of the muscle 
 Test protocol used in a fatigue study 
 Criteria for each participant 
2.1.1.1 Type of contraction selection 
Studies have indicated that, as opposed to a repetitive MVC task, central fatigue forms a 
greater proportion of the attenuated force during a submaximal isometric contraction (Søgaard 
et al, 2006; Taylor & Gandevia, 2008). 
For this study, a submaximal isometric concentration was selected to focus on central fatigue 
(for more detail on %MVC selected, see Section 2.1.1.3). 
2.1.1.2 Muscle selection 
Phillips and Porter (1964) observed that the cortico-motoneuronal connections to distal 
muscles are stronger than those to proximal muscles. Additionally, in order to prevent 
movement artefacts and excessive muscle activity interfering with the EEG (as this is a muscle 
fatigue study), a small muscle distal from the head and neck region would be ideal.   
Barandun et al. (2009) argued that since the abductor pollicis brevis (APB) muscle has one 
motor point, that there would be a high probability that any observed innervation zone (IZ) will 
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not extend into the measuring region. Additionally, the APB muscle is close to the surface 
under a thin layer of fat allowing for low impedances between the muscle fibre and electrode 
(Merletti & Parker, 2004).  
Therefore, for the present study, the APB, a distal muscle, was selected. Thus, as a result, the 
cortico-motoneuronal connections would be stronger and would prevent artefacts and 
excessive muscle activity interfering with the EEG signals. Additionally, the IZ in the APB muscle 
may be experimentally avoided, and the impedance between the muscle fibre and electrode 
would be small. 
2.1.1.3 Testing procedure from a fatigue study 
In order to allow for testing of pre-, during and post-fatigue, an experimental protocol was 
adopted from Kattla and Lowery (2010), who conducted a fatigue study that recorded EMG and 
force, in three: 
Stage 1: An initial non-fatiguing contraction at a 10% of MVC, allowing for a control-observed 
parameter for each participant 
Stage 2: Required the participant to fatigue the specific muscle at 30% of MVC. A participant 
was considered fatigued if the targeted %MVC dropped by 10% for longer than 2 
seconds.  
Stage 3: Performed the same task as in Stage 1, with no rest between Stage 2 and 3.  
Through these stages, a direct comparison of an observed parameter between Stage 1 and 3 
can be conducted. In addition the time course changes within Stage 2 may be observed.  
2.1.1.4 Participant inclusion and exclusion criteria  
In order to remove external factors that could influence the outcome, participants had to 
satisfy certain criteria to be selected.  These external factors included: 
 neurological diseases or pre-existing neurological conditions; and 
 the consumption of cigarettes, caffeine or alcohol before the experiment. 
Performance of muscle groups significantly differ with age and gender, for example. Dedrick et 
al. (2008) found that ‘female recreational athletes utilise a different neuromuscular control 
pattern for performing a drop jump sequence when estrogen levels are high compared to when 
they are low’. Thus, only male participants were selected, because it is uncertain to what 
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extent neuromuscular signals are affected by hormones, such as oestrogen and progesterone. 
In contrast, adult male testosterone levels remain relatively unchanged. 
2.1.1.5 Summary for criteria of experimental protocol  
 Participants selected for this study were healthy males from the same age group with 
no prior neurological disorders and no consumption of cigarettes, caffeine or alcohol 
before the experiment.  
 The muscle selected was the APB muscle. 
 A submaximal isometric contraction was used to fatigue the muscle.  
 The testing procedure would have three stages: pre-fatigue, fatigue and post-fatigue.  
2.1.2 Test protocol 
The Human Research Ethics Committee approved the ethics for testing before the experiments 
were carried out (HREC REF: 157/2011). 
Fifteen participants (see Appendix B for sample size estimation) were recruited from amongst 
the adult UCT student population (age: 25 ± 2 years). All participants were right-handed males 
with no history of neurological or muscular disorders, nor any epilepsy of any kind (refer to 
Section 2.1.1.4). 
Prior to testing, the detail of the study was thoroughly explained to each participant.  Each 
participant received a consent form (see Appendix C) explaining all the testing procedures, risks 
and benefits.  The study was performed in accordance with the principles of the Declaration of 
Helsinki (October, 2008), ICH Good Clinical Practice (GCP) and the laws of South Africa.  
Participants had the right to withdraw from the experiment at any stage without stating a 
reason and without prejudice. The investigators, who were working under the mandate of the 
University of Cape Town, were responsible for treating any adverse or untoward events arising 
from participation in this research study.  
In the present study, testing involved a three-step procedure. First, the participants were 
familiarised with the custom-designed isometric contraction device (refer to Section 2.1.3.1), 
and the details of the study were thoroughly explained to them. Second, each participant’s 
peak isometric force was assessed on the APB muscle using a custom designed and built 
isometric contraction device (see Section 2.1.3.1). The participant was seated with his right arm 
and hand strapped down. All isometric tests were conducted with the elbow flexed at 
approximately 90° (see Figure 2-10). When measuring the force output, the thumb would push 
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against the isometric contraction device at approximately 30° from the hand. A standardised 
warm-up included isometric contractions at 30%, 50% and 70%, followed by MVC of the 
participant’s perceived output. The test included three MVCs of 5 seconds, each separated by 
60-second intervals. Participants were verbally motivated to encourage them to achieve their 
maximum contraction. The maximum MVC value from these tests was selected as their MVC. 
Third, participants were prepared for the placement of the EMG and EEG electrodes and a 
prolonged resting period was given in order to prevent the onset of fatigue. Thereafter, the 
participant performed six isometric contractions at 10% of MVC for 10 seconds for the pre-
fatigue stage. After a 2-minute rest period, the participant performed an isometric contraction 
at 30% of MVC until task failure (when the % MVC dropped by 10%, in this case to below 20% 
of MVC for more than 2 seconds) for the fatigue stage. Following this, the participants repeated 
the six initial sub-maximal movements for the post-fatigue stage (see Figure 2-1). 
6 repetitive contractions at 
10% MVC held for 10 
seconds each
30% MVC isometric 
contraction till exhaustion 
(below 20% for more than 2 
seconds)
6 repetitive contractions at 
10% MVC held for 10 
seconds each
2 min rest No rest
 
Figure 2-1: Protocol for a single trial for a single participant.  
2.1.3 Recording 
Section 2.1.3 explains the recording of force, EMG and EEG signals during the experiment.  
2.1.3.1 Force recordings 
The experiment required an isometric contraction device with the following requirements: 
1. force output to be provided, 
2. APB muscle to be the primary mover for the movement required by the participant 
throughout the experiment, and 
3. adjustable for any right-handed person. 
The resulting design was conceptualised and developed in SOLIDWORKS Student version 2011. 
The device was made to attach to a Manipulandum design by Divekar and John (2012). Figure 




Figure 2-2: SOLIDWORKS design of the isometric contraction device. 
2.1.3.1.1 Output force measurement for the isometric contraction device 
The force applied by the APB muscle was determined with the use of mild steel, 2mm strain 
gauges (purchased from RS Components, South Africa,), which were placed on the APB 




Figure 2-3: Positioning of strain gauges: Strain gauges were placed behind and in front of the 
APB cantilever (see Figure 2-2) as shown by the red blocks and blue blocks, respectively. 
The four strain gauges formed a full-bridge strain gauge setup.  This was electrically connected 
to a commercial strain gauge amplifier (RS Components, Stock no. 435-692; refer to Appendix J) 
Strain gauges 
Manipulandum 
APB cantilever  
Hemispherical end 
Attachment designed by author 
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with a high common mode ratio (CMRR) (> 120 dB), low voltage offset w.r.t. temperature 
(0.5μV/°C for input voltage and 20μV/°C for bridge supply voltage) and high-precision resistors 
(1% tolerance and 50ppm/°C temperature coefficient) (see Figure 2-4). The bridge voltage 






𝑤ℎ𝑒𝑟𝑒 𝑅1 = 270 𝑘𝛺 𝑎𝑛𝑑 𝑅2 = 100 𝛺 
𝐺𝑎𝑖𝑛 = 2701  
Equation 2-1 
The output voltages from the strain gauge amplifier were digitally converted at 1 KHz and 
visually displayed to the participant and invigilator (refer to Section 2.1.4).  
 
Figure 2-4: a) the connection of the full-bridge strain gauge (see Figure 2-3) circuit to the b) 
commercial strain gauge amplifier (schematic adopted from RS Components Stock No. 435-692 
Datasheet).  The A, D, F and G outputs of the full-bridge stain gauges were connected to the 
Strain gauge 1 Strain gauge 3 









inputs of the commercial gauge amplifier. Output (E), the force applied by the participant in 
volts, was presented back to the participant on a monitor (see Section 2.1.4). 
2.1.3.1.2 Palmar abduction performed on the isometric contraction device 
The APB muscle was found to be most active during palmar abduction (van Oudenaarde and 
Oostendorp, 1995). Palmar abduction is defined as the movement of the thumb anteriorly, a 
direction perpendicular to the palm. In order to perform this movement, the hand and forearm 
are constrained in their neutral positions, while the thumb abducts against the APB cantilever 
(see Figure 2-5), thus performing a palmar abduction, while the hand remains in a neutral 
position.  
  
Figure 2-5: Top view (a) and front view (b) of a thumb performing a palmar abduction against the 
isometric device. The black padding around the hemispherical end (see Figure 2-2) was to provide 
cushioning for the thumb to make it more comfortable for the participant. 
2.1.3.1.3 Adjustable positioning of the isometric contraction device 
The hemispherical end (shown in Figure 2-2) was designed to be spherical in order to maintain 
consistency regarding the location of where the participants transferred their force to the 
cantilever.  
The APB cantilever was designed to be adjustable (i.e., move up or down, closer or further from 
the thumb and toward or away from the body). This was achieved by loosening the bolts shown 
in Figure 2-6 and adjusting the position of the APB cantilever, which allowed for a consistent 
angle between the thumb and index finger as well as keeping the interphalangeal joint of the 
thumb firm against the centre of the hemispherical end.  
b a 
Hemispherical end 
(see Figure 2-2) 
APB cantilever 






Figure 2-6: Side view of thumb pressing against the isometric contraction device.  
2.1.3.2 EMG recordings 
Keenan, Collins, Massey, Walters, and Gruszka (2011) observed that the EMG-EMG coherence 
can be altered if the distance from the IZ is not taken into account. Therefore, for this study, an 
electrode grid was used to first determine the IZ in the APB muscle. 
This design was based on an electrode grid by Nawab, Chang, and De Luca (2010) (see Figure 
2-7). Nawab et al. (2010) implemented a five-pin electrode grid, with each electrode being 
0.5mm in diameter: four-pin electrodes were placed in a square, 3.6mm apart from one 
another, and one pin in the centre of the square. This electrode grid was used for motor unit 
detection and IZ detection for a small hand muscle (the first dorsal interosseous muscle).  
 
Figure 2-7: Electrode grid developed by Nawab et al. (2010). 
The design for the present study used eight bipolar channels to form an electrode grid. Each 





another (see Figure 2-8a). The common reference for each bipolar channel was the ‘REF’ 
electrode (see Figure 2-8a). The grid was held down by MicroporeTM (see Figure 2-8b).   
The active ground electrode was a cup-type silver electrode (Nihon Kohden, Japan, diameter = 
10mm) and was placed over the ulnar styloid process. The active ground electrode, which is 
called the driven right leg (DRL), is used for noise cancelation presented on the EMG amplifier 
boards.  
Abrasion and cleaning (with ethanol) of the skin over the muscle was done prior to placing the 
electrodes. The electrode tips were lightly dipped in Elefix electrode paste (Nihon Kohden, 
Japan) to further reduce contact impedance.   The electrode grid was placed on the belly of the 
muscle, and the electrode ends were smoothed out, so they only indented and did not pierce 
the skin. The impedance of the EMG electrode pair were kept below 10 kΩ during the 
recording. 
  
Figure 2-8: a) Electrode grid showing the EMG channels. Each electrode was 1mm in diameter 
and the centres were 2.5mm from one another. The numbers represent the channel number 
of each electrode. b) Electrode grid was placed against the participant’s palm and covered by 
MicroporeTM to detect the APB EMG. 
 
The EMG data were recorded using bio-amplifiers with gains of 1800. The EMG data was 
filtered in the range of 5200 Hz. The original bio-amplifiers had been developed and used in 
the study by Divekar and John (2012).  
2.1.3.3 EEG recordings 
Sixteen tin electrodes on a commercial electrode cap (electro-cap) were modified from  Divekar 
and John's (2012) study and were used in this study. The 16 electrodes placed on the cap are 
shown in Figure 2-9. Electrolyte gel was placed in each electrode to allow contact between the 
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electrode and scalp. Impedance of the EEG electrodes was kept below 5 kΩ during the 
recording. The ground electrode was Pz and the DRL was on FPz.  
The final setup of the experiment is shown in Figure 2-10. 
 
Figure 2-9: Selected 16-channel EEG montage following international 10-10 system spacing for 
EEG detection with the ground at Pz and the DRL at FPz. Note that the view is of the top of the 
head, with a schematic of the nose identifying the anterior part  (Divekar & John, 2012). 
EEG data were recorded using bio-amplifiers with gains of ≈ 5000. The data was off-line filtered 
in the range of 0.1200 Hz. The bio-amplifiers had been developed and used in the study of 
Divekar and John (2012).  
 
Figure 2-10: Final setup of a participant before the experiment began. 
The isometric contraction device (see Figure 2-2) 
16-channel EEG cap (see Figure 2-9) 
Manipulandum 
8-channel EMG electrode grid 
(see Figure 2-8) 
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2.1.4 Data acquisition of force, EMG and EEG  
After pre-processing and sensor amplification (see Section 2.1.3), the data were digitally 
sampled and acquired using a 16-channel NI DAQ (National Instruments Data Acquisition 6210) 
for the EEG, which was synchronised with a second 16-channel NI DAQ for EMG and force, as 
shown in Figure 2-11. All of the data was digitalised at 1 kHz with a 16-bit resolution (Divekar & 
John, 2012). 
 
Figure 2-11: Block diagram of the overall system used during the experiment, which includes 
the %MVC visual feedback, EEG, EMG and force recordings.  
The user interface application between the recording device and invigilator (i.e. the author) 
was developed by the author using National Instruments LabVIEW 2010. This application 
contained two user interface screens, one for the participant and one for the invigilator.  
The invigilator, who controls the experiment, has a screen which shows raw EEG and EMG 
signals, force in volts, time elapsed for single experimental stage and switches to select which 





EMG and force 
outputs 








digitised by a 16-
channel NI DAQ 
EMG and force 
data digitised by 
a 16-channel NI 
DAQ 
LabVIEW PC (see 
Figure 2-12) 
Force circle controlled by 
digitised force from LabVIEW 




Figure 2-12: Invigilator's testing screen during an experiment. The graphs, a) EEG and c) EMG, 
show raw EMG and EEG signals from the participants. d) ‘F_real’ and ‘F%’ show the strain gauge 
output in voltage and the percentage of the MVC of the participant respectively (refer to Figure 
E-5). b) The switches allowed the invigilator to select which stage of the experiment should be 
performed.  
The participants’ screen (see Figure 2-13) provides visual feedback of the %MVC applied by the 
participant. The screen was turned off during the MVC tests and only turned on during the pre-
fatigue, fatigue and post-fatigue stage. The screen shows a black dot and a circle within a larger 
circle. When force is applied to the hemispherical end of the isometric contraction device (see 
Figure 2-5), the black dot slides from right to left (lower %MVC to higher %MVC), with the 
midpoint being the targeted %MVC. The inner circle indicates a range of 2% of the targeted 
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Figure 2-13:  Five examples of screens shown to the participants during the experiment. The 
black dot within the circle slides from right to left (lower %MVC to higher %MVC). The midpoint 
is the targeted %MVC percentage (i.e., 10% or 30%, depending on the experimental stage) for 
the participant. The inner circle indicates the range within 2% of the targeted MVC and the 
outer circle indicates the range within 4% of the targeted MVC. The visual angle of the circle 
was small in order to minimise the participant’s eye movement. 
A summary of the steps undertaken by the invigilator is described in Figure 2-14. The data was 
then saved into a text file for offline analysis, which was conducted later using MATLAB R2011 
(see Sections 2.1.5, 2.2 and 2.3). A single stage per participant contains two files: one 




Figure 2-14: Description of the invigilator’s test protocol. 
Explanation of the study and consent form was handed to the participant  
Participant was seated with his elbow flexed at approximately 90° with his hand placed in the Manipulandum. His 
forearm was strapped down; the interphalangeal joint was checked to be against the hemispherical end, and the 
angle between his hand and thumb was approximately 30° (see Figure 2-5).  
For warm-up, the participant was asked to press against the hemispherical end (see Figure 2-5) at what he 
perceived was his 30%, 50%, 70% and 100% MVC. Then, he was given 2 minutes to rest. Following that, another 
three 100% of MVC tests were done, each 5 seconds long, with a 60-second break between each movement. The 
highest MVC that was recorded was entered into the invigilator's testing screen (see Figure 2-12) to determine the 
participant’s 10% and 30% of MVC.  
The participant was then fitted with the 16-channel EEG cap. Electrolyte gel was placed in each electrode to allow 
contact between the electrode and scalp. All impendences were checked to be below 5 kΩ (see Section 2.1.3.3). 
LabVIEW computer was started up and displayed the invigilator’s test screen (see Figure 2-12) and participant‘s 
testing screen (see Figure 2-13). The participant‘s screen was turned off during the %MVC test. 
Abrasion and cleaning (with ethanol) of the skin over the APB muscle was done. Prior to placing the EMG 
electrode grid, electrode tips were lightly dipped in Elefix electrode paste to further reduce impedance. The EMG 
grid electrode was placed over the APB muscle in line with the muscle fibre. MicroporeTM was taped around the 
participant’s hand to hold the EMG electrode grid in place. All impendences were checked to be below 20 kΩ (see 
Section 2.1.3.3).  
The participant’s screen was turned on. The participant was asked to press lightly on the isometric device and 
clench his jaws. The invigilator checked the EMG, EEG and force signals. The invigilator also checked whether the 
black dot moved as the participant pressed against the isometric contraction device. Then the participant was 
given another 2 minutes to rest to avoid fatigue.   
For the pre-fatigue stage, the participant was asked to press on the isometric device at 10% of MVC with the help 
of visual feedback from the participant’s screen (see Figure 2-13). Once the black dot was approximately at the 
mid-point, the invigilator would start recording for 10 seconds. This was repeated six times. Then the participant 
was given another 2 minutes to rest to avoid fatigue.   
For the fatigue stage, the participant was asked to press on the isometric device at 30% of MVC with the help of 
visual feedback from the participant’s screen (see Figure 2-13). Once the black dot was approximately at the mid-
point, the invigilator would start recording. The program would stop recording once the participant dropped 
below 20% of MVC for longer than 2 seconds.  
With no rest, for the post-fatigue stage, the participant was then asked to press on the isometric device at 10% of 
MVC with the help of visual feedback from the participant’s screen (see Figure 2-13). Once the black dot was 




2.1.5 Software pre-processing of raw EMG, EEG and force signals 
Section 2.1.5 deals with the software pre-processing of force, EMG and EEG signals acquired 
during the experiment. 
2.1.5.1 Extraction of participant data  
Data files containing the recordings were first separated according to their respective names. 
Each stage per participant contained two files (one file from each of the two DAQs used). One 
file contained 16-channel EEGs, while the other contained 8-channel EMGs and a single force 
channel.  The files were loaded into MATLAB as a matrix, where each column represented a 
different EMG, EEG or force channel (see Code G-1). 
2.1.5.2 Software pre-processing of data 
The data was pre-processed to remove noise from the signal and then filtered to remove low 
frequencies caused by movement and high frequencies to avoid signal aliasing (Gerdle et al., 
1999). The EMG, EEG and force data were filtered with a fourth-order zero-phase-shift 
Butterworth filter between 0.5100 Hz, 10200 Hz and a low pass filter of 200 Hz, respectively 
(see Code G-2). 
The gains by the bio-amplifier boards to the EEG and EMG signals (see Section 2.1.3.2 and 
2.1.3.3) were corrected for to determine the actual EEG and EMG voltages i.e. EEG data was 
divided by 5000 and EMG data was divided by 1800 (see Code G-3). 
The EEG voltage signals were converted to current source density estimates using the spherical 
splines algorithm (Kayser, 2001).   
Once a bipolar EMG channel was selected based on the muscle IZ (refer to Section 2.3.1), the 
data was rectified to boost the progressive pattern of grouped firing motor units (Halliday & 
Farmer, 2010) (see Code G-4). 
Section 3.1 illustrates the raw EMG, EEG and force waveforms with their respective PSDs, pre- 




2.2 Muscle fatigue influence on force, EMG and EEG  
Section 2.2 deals with data analysis for measuring the influence of muscle fatigue on force, 
EMG and EEG, as shown in previous studies mentioned in Section 1.2.2. This was done to 
validate the experimental protocol. 
2.2.1 Power spectral density (PSD) 
The power spectrum of a signal can be used to determine the dominant frequencies within that 
signal. For this study, the Welch method was used to determine the power spectral to provide 
information on the predominant frequencies (see Code G-5). 
𝐸𝑀𝐺𝑃𝑆𝐷 = 𝑃𝐸𝑀𝐺(𝑓) Equation 2-2 
2.2.2 Coefficient of variance of force (forceCV) 
The forcecv was the ratio of the standard deviation to the mean of the force acquired, which 




∗ 100 Equation 2-3 
where 𝜎is the standard deviation of the force acquired and 𝜇  is the mean of the force acquired 
(see Code G-6). 
2.2.3 Normalised beta force power spectral density (beta forcePSD) 
The normalised beta (15-35 Hz) forcePSD was calculated using the power spectral density 
derived from the Welch method, and then the following equation was used: 









 where 𝑃𝐹𝑜𝑟𝑐𝑒 is the PSD of the actual force in %MVC (see Code G-10). 
2.2.4 EMG root mean squared (EMGRMS) 













2.2.5 EMG mean power frequency (EMGMPF) 
The mean power frequency was calculated as the sum of the product of the power spectrum 
and the frequency, divided by the total sum of the power spectrum (an alternative method for 
measuring the mean frequency, not trial-dependent, is shown in Appendix F). The power 
spectrum was determined using the Welch method (see Code G-8). 
𝐸𝑀𝐺𝑀𝑃𝐹 =









2.2.6 Beta EEG root mean squared (beta EEGRMS) 
The EEG data were first filtered between 15Hz35 Hz (beta band) using a fourth-order zero-
phase-shift Butterworth filter. The beta EEGRMS was found using the following formula (see 









 𝑛 = 𝑙𝑒𝑛𝑔𝑡ℎ 𝑜𝑓 𝑡ℎ𝑒 𝑠𝑖𝑔𝑛𝑎𝑙 
Equation 2-7 
2.2.7 Statistical analysis for muscle fatigue influence on force, EMG and EEG 
Statistical analysis of the data was carried out using SPSS v19. 
The experiment contained 3 stages: pre-fatigue, fatigue and post-fatigue. The fatigue stage was 
designed to fatigue the participant’s APB muscle, while the pre-fatigue stage determined a 
control value for each participant. Finally, the post-fatigue stage was compared to the pre-
fatigue stage to determine the change in the observed parameters, due to the effect of muscle 
fatigue (see Section 2.1.1). 
The six repetitions of 10 seconds within the pre-fatigue stage were grouped to form one 60-
second stage; similarly, the six repetitions of 10 seconds within the post-fatigue stage were 
grouped to form one 60-second stage.  ForceCV, normalised beta forcePSD, EMGRMS, EMGMPF, and 
beta EEGRMS was then applied to the 60-second block for pre-fatigue and post-fatigue. 
Thereafter, a paired t-test was carried out for all 15 participants in order to test the effect of 
the independent variables (IVs, pre- and post-fatigue) on the dependent variables (DVs, forceCV, 
normalised beta forcePSD, EMGRMS, EMGMPF, and beta EEGRMS).   
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The following assumptions were considered when preparing for the paired t-test: 
1. The DV should be measured on a continuous scale. In this study, the DVs are observed 
to be on a continuous scale. 
2. The IV should consist of related groups. In this study, the participants’ pre- and post-
fatigue remained the same; thus, the groups are related.  
3. There are no significant outliers in the differences between the two related groups. 
This was verified by plotting a box plot for each observed parameter, shown in 
Appendix J below each measure. 
4. The distribution of the differences in the dependent variable between the two related 
groups should be approximately normally distributed. This was verified by doing a 
Shapiro-Wilk test of normality, as shown in Appendix J below each measure.  
Section 3.1.2 validates the fatigue stage by plotting the time course changes in forceCV, 
normalised beta forcePSD, EMGRMS, EMGMPF and beta EEGRMS for a typical participant, while 
Section 3.2.1 shows the statistical results of forceCV, normalised beta forcePSD, EMGRMS, EMGMPF 
and beta EEGRMS in regards to the effect of muscle fatigue. 
However, it should be noted that, in order to remove any outliers for the statistical results 
between participants, the EMG amplitudes and EEG amplitudes for each participant were 
normalised with their peak EMG and peak EEG amplitudes (found within each participant 
throughout the experiment) respectively (Halaki and Ginn, 2012).  
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2.3 Corticomuscular coupling measures  
Section 2.3 deals with determining a suitable EEG and EMG electrode pair for the 
corticomuscular coupling measures as well as determining the transition to fatigue during the 
fatigue stage. Finally, this section denotes the data analysis for corticomuscular coupling 
measures. Section 1.2.3 forms the literature background for this section.  
2.3.1 Selection of EMG channel for corticomuscular coupling measures 
The method of determining the IZ was adopted from the study published by Keenan et al. 
(2012) (see Section 1.2.3.3). Each participant’s IZ was selected visually by checking the 
waveforms, similar to Figure 3-3.  
In this study, the eight-channel electrode grid was placed parallel to the motor fibres (shown in 
Figure 2-8b). The bipolar differences between the two adjacent electrodes (i.e., electrode 12, 
2-ref, ref-7 and 78 shown in Section 3.1.3.1) were observed to identify the IZ zone, which was 
estimated to be between two bipolar channels with a clear polarity change.   
Since the bipolar channel furthest from the innervation has been shown to provide greater 
EMG-EMG coherence amplitude peaks (Keenan et al., 2012), the electrode channel furthest 
from the IZ was selected.  The selected EMG electrode is called EMGSELECT and may vary 
between participants. 
2.3.2 Selection of EEG channel for corticomuscular coupling measures 
As mentioned in Section 1.2.3.4, the electrodes in the contra-lateral sensorimotor region were 
selected (C1, C3, C5, FC3 and CP3). 
To verify that these electrodes were indeed the most relevant ones, an EEG topographical plot 
for pre- and post-fatigue beta EEG-EMG coherence and beta EEG-EMG PLV peak amplitudes 
(see Figure 3-4) was generated using a topographical plotting function from an open source 
toolbox in MATLAB, known as EEGLAB (Delorme & Makeig, 2004). The selected EEG electrode 
was the contralateral one with maximal coherence or PLV (respectively) to the selected EMG 
channel, and is called EEGSELECT. 
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2.3.3 Transition to fatigue  
As mentioned in Section 1.2.3.5, the transition to fatigue time point was determined in order to 
examine the corticomuscular coupling during the fatigue stage. The transition to fatigue time 
point is found when 1D spectro increases (see Figure 2-15). 
 
Figure 2-15: Determination of the transition to fatigue point using a 1D spectro waveform. The 
figure adopted from Al-Mulla and Sepulveda (2010). 
Since it was unclear from Al-Mulla and Sepulveda’s (2010) study on how the EMGPOWER and 
EMGMDF were scaled before subtracting, the present study assumed it was normalised. Thus, 
for the present study, the transition to fatigue time point is manually identified by visually 
selecting the time point when 1D spectro increases (i.e. when ‘normalised EMGPOWER’ 
subtracted from the ‘normalised EMGMDF’ increases)  
1. EMGPOWER in the 5-200 Hz band was determined using the following equation: 











2. EMGMDF was determined using the following equation: 








3. Normalise EMGPOWER and EMGMDF using the following equations: 
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑠𝑒𝑑 𝐸𝑀𝐺𝑃𝑂𝑊𝐸𝑅 =  𝐸𝑀𝐺𝑃𝑂𝑊𝐸𝑅/ max (𝐸𝑀𝐺𝑃𝑂𝑊𝐸𝑅) Equation 2-10 
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑠𝑒𝑑 𝐸𝑀𝐺𝑀𝐷𝐹 =  𝐸𝑀𝐺𝑀𝐷𝐹/ max (𝐸𝑀𝐺𝑀𝐷𝐹) Equation 2-11 
 
4. 1D spectro was estimated using the following formula (see Code G-15): 
1𝐷 𝑠𝑝𝑒𝑐𝑡𝑟𝑜 =  𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑠𝑒𝑑 𝐸𝑀𝐺𝑃𝑂𝑊𝐸𝑅 − 𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑠𝑒𝑑 𝐸𝑀𝐺𝑀𝐷𝐹 Equation 2-12 
The EMGPOWER, EMGMDF and 1D spectro of a typical participant during the fatigue stage were 
illustrated by sliding a 30-second window along the signal in 1-second increments (see Figure 
3-6). 
2.3.4 EEG-EMG coherence 
As discussed in Section 1.2.3.1, EEG-EMG coherence is one of the measures of corticomuscular 
coupling. In this study, electrodes EMGSELECT and EEGSELECT (refer to Section 2.3.1 and 2.3.2) were 
provided as the inputs to measure EEG-EMG coherence using a function in MATLAB, called 
‘mscohere’ (Magnitude squared coherence; refer to Code G-12).  
The magnitude squared coherence estimate, 𝐶𝑥𝑦, of the input signals x and y using Welch's 
averaged, modified periodogram method. 𝐶𝑥𝑦 a function of frequency with values between 0 
and 1 that indicates how well x corresponds to y at each frequency, 0 (if the signals are 








where  𝑃𝑥𝑥(𝑓) and 𝑃𝑦𝑦(𝑓) are the power spectral densities of x and y, respectively, and 𝑃𝑥𝑦(𝑓) 
is the cross power spectral density of x and y. 
The coherence estimate was considered significant where 𝐶𝑥𝑦 > 𝐶𝑜𝑛𝑓𝑖𝑑𝑒𝑛𝑐𝑒 𝐿𝑒𝑣𝑒𝑙 (𝐶𝐿). 
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where L is the total number of disjointed segments used to calculate the coherence and α = 
0.05 (i.e., above the 95% confidence interval) (Rosenberg, Amjad, Breeze, Brillinger, & Halliday, 
1989). 
The window size used for the ‘mscohere’ was 256 samples (i.e., 256 ms since the sample rate 
was 1 Khz), which can capture frequencies as low as 4 Hz. Since the study was related to the 
EEG-EMG coherence in the beta band (1535 Hz), this window size proved to be adequate. 
The 6 repetitions of 10 seconds within the pre-fatigue stage were grouped to form a 60-second 
stage; similarly, the six repetitions of 10 seconds within the post-fatigue stage were grouped to 
form one 60-second stage.  Thereafter, the EEG-EMG coherence waveforms were generated 
for both pre- and post-fatigue stages. Thus, in this study, L for Equation 2-14 is approximately 
234 and CL is 0.0128. 
2.3.5 EEG- EMG phase lock value (EEG-EMG PLV) 
As discussed in Section 1.2.3.2, the EEG-EMG PLV is another one of the measures of 
corticomuscular coupling. Figure 2-16 help illustrate the method of determining the PLV and 




Figure 2-16: Illustration of the method of determining PLV and PLS waveforms in the present 
study. 
Pre-processed EEG signal  Pre-processed rectified EMG signal  
Phase of EMG (𝜑𝑌𝑖) Phase of EEG (𝜑𝑋𝑖) 
Narrow band-filtered EEG Data Narrow band-filtered EMG Data 
Find the mean PLV for a frequency 
point 
Repeated for every frequency 
point  
EEG-EMG PLV vs. frequency   
FIR Filter  
Hilbert Transform 
Develop 100 random phase shifted 
signals (𝑛𝜑𝑌𝑖) where n = 1...100 
PLV for each sample point 
100 separate PLVs for each sample 
point 
For each signal find the mean PLV 
value for a frequency point 
PLS = 95% percentile of the 100 
PLV values 
Repeated for every frequency 
point  
EEG-EMG PLS vs. frequency   
𝑒−𝑗(𝜑𝑋𝑖−𝑛𝜑𝑌𝑖) 





To determine EEG-EMG PLV, EEG and EMG data were first narrow-band filtered (𝑓𝑐 ± 0.5𝐻𝑧), 
using finite impulse response (FIR) filter for each frequency point (𝑓𝑐).  
EEG-EMG PLV for 𝑓𝑐 was calculated using the following equation (adopted from Lachaux et al., 
1999): 








where 𝑖 is a sample point; 𝜃𝑖 = 𝜑𝑋𝑖 − 𝜑𝑌𝑖  is the phase difference between the two signals and 
𝑛 is the length of the signal. 
In this study, electrodes EMGSELECT and EEGSELECT (refer to Section 2.3.1 and 2.3.2) were used to 
measure the EEG-EMG PLV using a MATLAB function developed by the author (see Code G-13). 
The instantaneous phase was found for each signal using the Hilbert transform, which was 
chosen because there were minor differences found between using the wavelet and Hilbert 
transforms for neurological signals (Le Van Quyen et al., 2001) and the Hilbert transform was 
preferred as it requires less computational time.   
The EEG-EMG PLVs were calculated using a bootstrap technique on 100 ‘shift surrogates’. 
These ‘shift surrogates’ were generated by time shifting one series relative to the other by 
random lags. By using the ‘shift surrogates’ as opposed to ‘shuffled surrogates’ (which are 
generated by shuffling the samples within one time series), the timing structure of the signal 
was maintained. Additionally, it was shown to preserve the inherent autocorrelations of the 
signals and only remove the cross-correlations. This method was adopted from Gupta and 
James (2007). 
Therefore, the EEG-EMG PLV was deemed significant if it fell above the 95th percentile (EEG-
EMG PLS) of the 100 shifted surrogates (refer to Code G-14). 
Since phase difference was determined between two different neurological systems, the phase 
locking ratio, (𝜃𝑖 = 𝑛𝜑𝑋𝑖 − 𝑚𝜑𝑌𝑖) where 𝑛: 𝑚=2:1(EMG phase: EEG phase), should be used. 




2.3.6 Statistical analysis for corticomuscular coupling measures pre- and post-
fatigue 
As discussed in Section 2.2.7 pre- and post-fatigue were grouped to form two 60-second stage 
blocks. Thereafter, the EEG-EMG coherence waveforms and the EEG-EMG PLV waveforms were 
generated for both pre- and post-fatigue (see Section 3.1.3.3). For each participant, the 
maximum beta EEG-EMG coherence and beta EEG-EMG PLV amplitude (beta EEG-EMG 
coherencePEAK AMP and beta EEG-EMG PLVPEAK AMP) with their respective frequencies (beta EEG-
EMG coherence PEAK FREQ and beta EEG-EMG PLVPEAK FREQ) were found in the beta band for the 
pre-fatigue stage and post-fatigue stage (see Figure 3-5). 
A paired t-test was carried out to test the effect of the IVs (pre- and post-fatigue) on the DVs 
(beta EEG-EMG coherence PEAK AMP and beta PLVPEAK AMP) for all 15 participants.  The same 
assumptions shown in Section 2.2.7 for the paired t-test were considered. 
Section 3.1.3.3 illustrates an example of a typical participant’s EEG-EMG coherence and EEG-
EMG PLV waveforms pre- and post-fatigue, while Section 3.2.2 shows the statistical results for 
beta EEG-EMG coherence PEAK AMP and beta EEG-EMG PLVPEAK AMP pre- and post-fatigue.  
2.3.7 Statistical analysis for corticomuscular coupling measures before and after 
transition to fatigue  
A non-parametric signed test was carried out in order to examine the corticomuscular coupling 
during the fatigue stage (as paired t-test failed the assumption of no outliers even after the 
application of the arc hyperbolic tangent transformation, Rosenberg et al., 1989).  
Two blocks of 30 seconds before and after the transition to fatigue point (see Section 2.3.3) 
were segmented from the fatigue stage and defined as the first part of the fatigue stage and 
second part of the fatigue stage. Thereafter, the EEG-EMG coherence waveforms and the EEG-
EMG PLV waveforms were generated for both the first part of the fatigue stage and second part 
of the fatigue stage (see Section 3.1.3.3). For each participant, the maximum beta EEG-EMG 
coherence and beta EEG-EMG PLV amplitude (beta EEG-EMG coherencePEAK AMP and beta EEG-
EMG PLVPEAK AMP) with their respective frequencies (beta EEG-EMG coherence PEAK FREQ and beta 
EEG-EMG PLVPEAK FREQ) were found in the beta band for the before and after the transition to 
fatigue (see Figure 3-7). The non-parametric signed test measured the effect of the IVs (first 
part of the fatigue stage and second part of the fatigue stage) on the DVs (beta EEG-EMG 




In order to perform a non-parametric signed test, the following assumptions were considered: 
1. The differences are independent from one other, as the one participant cannot affect 
another participant’s values. 
2. The populations before and after are related. 
3. The dependent variables are from a continuous scale. 
Also, since the aim of the study is to determine the confounding effects of both the EEG and 
EMG amplitudes on the beta EEG-EMG coherence PEAK AMP, a paired t-test was carried out on 
both the EEGRMS and EMGRMS. The paired t-test assessed the effect of the IVs (30 seconds 
before and 30 seconds after the transition to fatigue point) on the DVs (beta EEGRMS and 
normalised beta EMGRMS) for all 15 participants. The same assumptions shown in Section 2.2.7 
for the paired t-test were considered. 
Section 3.1.3.5 illustrates an example of a typical participant’s EEG-EMG coherence and EEG-
EMG PLV waveforms before and after the transition to fatigue, while Section 3.1.3.4 shows the 
time course changes for EMGPOWER, EMGMDF, 1D spectro, beta EMGRMS, beta EEGRMS, EEG-EMG 
coherence and EEG-EMG PLV. 
 Section 3.2.3 shows the statistical results for beta EMGRMS, beta EEGRMS, beta EEG-EMG 
coherencePEAK AMP and beta EEG-EMG PLVPEAK AMP before and after the transition to fatigue.  
However, notably, EMG amplitudes and EEG amplitudes for each participant was normalised 
with the peak EMG and peak EEG amplitudes (found within each participant throughout the 
experiment) respectively, in order to remove any outliers for the statistical results between 










Section 3 presents the results of the experiments that were carried out in order to test the 
present study’s objectives. Section 3.1 presents the qualitative results, while Section 3.2 
presents the quantitative results.  
3.1 Qualitative results 
Section 3.1 presents the qualitative results obtained from the experiments carried out in 
Section 2.  
3.1.1 Experimental protocol results 
This section deals with results obtained from the experiments carried out in Section 2.1. 
Figure 3-1 illustrates typical examples of one second EEGRAW, EMGRAW, force, EMGPSD, EEGPSD and 
forcePSD pre- and post-fatigue.  
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Figure 3-1: Pre- and post-fatigue comparisons between typical (a) EEGRAW, (b) EMGRAW and (c) 
force and (e, f, and g) their respective PSDs during a sustained isometric contraction at 10% 
MVC.  
The EEGPSD shown in Figure 3-1d is the power spectrum of EEGRAW, shown in Figure 3-1a. It can 
be observed that EEGPSD peaks in the beta band were clearer and more distinct post-fatigue 
compared to the pre-fatigue. Additionally, the EEGPSD for both the pre-fatigue and post-fatigue 
stages, was predominated by alpha oscillatory activity. 
The rectified EMGPSD shown in Figure 3-1e, is the power spectrum of rectified EMGRAW shown in 
Figure 3-1b. The rectified EMGPSD waveforms showed an increase in the beta band post-fatigue 
as compared to pre-fatigue.  










































The forcePSD shown in Figure 3-1f, is the power spectrum of the force shown in Figure 3-1c. It 
can be observed that the fluctuations were greater post-fatigue compared to pre-fatigue. This 
difference is more apparent in the beta band.  
3.1.2 Muscle fatigue influence on force, EMG and EEG  
This section deals with results obtained from the data analysis carried out in Section 2.2. 
Figure 3-2 illustrates the force, EMGRAW, EEGRAW, forceCV, normalised beta forcePSD, EMGRMS, 
EMGMPF and beta EEGRMS during sustained isometric contraction of the APB muscle at 30% of 
MVC until task failure. ForceCV, normalised beta forcePSD, EMGRMS, EMGMPF and beta EEGRMS were 










































































































































  time(s) 
Figure 3-2: Typical example of a participant showing progressive changes in (a) force, (b) 
EMGRAW, (c) EEGRAW, (d) forceCV, (e) normalised beta forcePSD, (f) EMGRMS, (g) EMGMPF and (h) 
beta EEGRMS during a sustained isometric contraction of the APB muscle at 30% of MVC until 
task failure. ForceCV, normalised beta forcePSD, EMGRMS, EMGMPF and beta EEGRMS were 
calculated by sliding a 30-second window along the signal in 1-second increments. 
From Figure 3-2a, Figure 3-2d and Figure 3-2e, it can be noted that the force, forceCV and 
normalised beta forcePSD during the fatigue stage were initially steady, but toward the last third 
of the fatigue stage, the normalised beta forcePSD began to fluctuate and forceCV started to 
increase.  
From Figure 3-2b and Figure 3-2f, it can be noted that EMGRAW and EMGRMS during the fatigue 
stage, were initially steady but toward the last third of the fatigue stage it began to gradually 
increased toward the end of the fatigue stage.  
From, Figure 3-2g it can be observed that EMGMPF during the fatigue stage decreased gradually 
and then levelled off toward the last sixth of the fatigue stage. 
From Figure 3-2c, it can be observed that EEGRAW, and Figure 3-2h, beta EEGRMS during the 
fatigue stage were initially steady, but just after the last third of the fatigue stage, the beta 













3.1.3 Corticomuscular coupling results  
This section discuss the results obtained from the data analysis carried out in Section 2.3.   
3.1.3.1 Electromyogram channel selection (EMGSELECT) 
Figure 3-3 illustrates a typical example of the raw EMG waveforms from the electrode grid 
during the fatigue stage.  
 
Figure 3-3: Detection of the IZ of a participant: a) Photo of the electrode grid that was placed 
on the APB muscle, with the longitudinal electrodes parallel to the muscle fibre. The numbers 
in black on each electrode indicate the electrode numbers. b) Provides a visual representation 
for the extraction of raw EMG signals between adjacent electrodes. c) Illustrates a section of 
raw EMG signals obtained from the difference of adjacent electrodes. This was used in 
determining the location of IZ as explained in Section 2.3.1.  
From Figure 3-3c, which shows the EMGRAW signals, it can be observed that there was a polarity 
change between the bipolar channels ‘8’-‘7’ and ‘REF’-‘2’. Therefore, the IZ was determined to 
approximately be somewhere between these channels, as explained in Section 2.3.1. 
Subsequently, the EMGSELECT for this participant was the pair furthest from the IZ (i.e., bipolar 
channel 2-1).   
The electrode grid was smaller than the length of APB muscle. As a result, for 4 out the 15 
participants, the IZ could not be detected post-processing. However, from Section 1.2.3.3 it can 
be observed that EMG signals further from the IZ have greater amplitudes. Thus, the EMGSELECT 
































3.1.3.2 Electroencephalography channel selection (EEGSELECT) 
Figure 3-4 illustrates the topographic view of the values, both pre- and post-fatigue, for the 
beta EEG-EMG coherence PEAK AMP and the beta EEG-EMG PLV PEAK AMP. 
















































































Figure 3-4: Topographical plots for (a) the beta EEG-EMG coherence PEAK AMP and (b)the beta 
EEG-EMG PLV PEAK AMP values pre-and post-fatigue during a sustained 10% of MVC isometric 
contraction of the APB muscle for a participant. Note that the view is of the top of the head, 
with a schematic of the nose identifying the anterior. The electrode labels are based on the 
international 10-10 system spacing. 
From Figure 3-4, it can be observed that the EEG channels with the beta EEG-EMG PLV PEAK AMP 
and the beta EEG-EMG coherence PEAK AMP values were found in the contra-lateral (i.e., left side 
























































































Subsequently, the EEGSELECT for the beta EEG-EMG coherencePEAK AMP analysis had the peak EEG-
EMG coherence amplitude in the beta band (1535 Hz) from C1, C3, C5, CP3 or FC3. The 
EEGSELECT for the beta EEG-EMG PLVPEAK AMP analysis had the peak EEG-EMG PLV amplitude in the 
beta band (1535 Hz) from C1, C3, C5, CP3 or FC3 (refer to Figure 2-9). 
3.1.3.3 Corticomuscular coupling waveforms pre- and post-fatigue 
Figure 3-5 illustrates the EEG-EMG coherence and the EEG-EMG PLV, pre- and post-fatigue.  










































  frequency (Hz) frequency (Hz) 
Figure 3-5:  Pre- and post-fatigue comparisons of (a) EEG-EMG coherence and (b) EEG-EMG PLV 
while performing a sustained isometric contraction at 10% of MVC where pp = beta EEG-EMG 
PLVPEAK AMP, pc = beta EEG-EMG coherencePEAK AMP, fc = beta EEG-EMG coherencePEAK FREQ and fp = 
beta EEG-EMG PLVPEAK FREQ. The estimated PLS and CL for the EEG-EMG PLV and the EEG-EMG 
coherence, respectively, is shown by the black lines within their respective graph. The EEG 
electrode used to determine the waveforms is displayed on the right side of each graph, and 
the corresponding EMG electrode was selected according to the procedure discussed in Section 
3.1.3.1. 
From Figure 3-5, the EEG-EMG coherence and EEG-EMG PLV waveforms have a greater peak 
post-fatigue as compared to pre-fatigue. For both stages (pre- and post-fatigue), the peaks 
were constrained to the beta band for the EEG-EMG coherence and the EEG-EMG PLV. (See 
Appendix H3 for the EEG-EMG coherence and EEG-EMG PLV waveforms for all 15 participants). 
  

























3.1.3.4 Transition to fatigue  
Figure 3-6 illustrates the EMGPOWER, EMGMDF, 1D spectro, beta EMGRMS (mV), beta EEGRMS (mV), 
EEG-EMG coherence and EEG-EMG PLV of a typical participant during the fatigue stage, which 
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EEG-EMG PLV amplitude (EEG electrode C3) 
 
  time(s) 
Figure 3-6: The a) EMGPOWER, b) EMGMDF, c) 1D spectro, d) beta EMGRMS, e) beta EEGRMS, f) EEG-
EMG coherence and g) EEG-EMG PLV of a typical participant during the fatigue stage was 
calculated by sliding a 30-second window along the signal in 1-second increments. The 
coloured bar above graph f and g represents the EEG-EMG coherence amplitudes and the EEG-
EMG PLV amplitudes respectively. Graph c denotes the transition to the fatigue time point at 
approximately 90 seconds.  
Figure 3-6a and Figure 3-6d observed that the EMGPOWER and beta EMGRMS were initially 
constant, then gradually increased after the transition to fatigue point and then levelled off 
toward the end of the fatigue stage. 
Figure 3-6b shows that the EMGMDF gradually decreased and then levelled off as EMGPOWER 
levelled off toward the end of the fatigue stage. 
In Figure 3-6c, it can be observed that the 1D spectro was initially constant, then gradually 
increased when the EMGPOWER increased, but finally slightly fluctuated toward the end of the 
fatigue stage. The transition to fatigue point was selected when the 1D spectro increased, 
which was approximately 90 seconds for this participant. 
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Figure 3-6e was mentioned in Section 3.1.2. 
From Figure 3-6f and Figure 3-6g, greater peaks for both the EEG-EMG coherence and the EEG-
EMG PLV in the beta band can be observed before the transition to fatigue. Gamma band peaks 
for both the EEG-EMG coherence and the EEG-EMG PLV occurred toward the end of the fatigue 
stage, but this was not the case for all participants.  However, notably, the EEG-EMG coherence 
and EEG-EMG PLV seem to follow the same peak amplitude values, except after the transition 




3.1.3.5 Corticomuscular coupling waveforms for the first and second part of the fatigue 
stage 
Figure 3-7 illustrates the EEG-EMG coherence and the EEG-EMG phase lock value (PLV) during 
the first and second part of the fatigue stage. 










































  frequency (Hz) frequency (Hz) 
Figure 3-7: First part and the second part of the fatigue stage comparisons of (a) EEG-EMG 
coherence and (b) EEG-EMG PLV while performing a sustained isometric contraction at 30% of 
MVC where pp = beta PLVPEAK AMP, pc = beta EEG-EMG coherencePEAK AMP, fc = beta EEG-EMG 
coherencePEAK FREQ and fp = beta PLVPEAK FREQ. The estimated PLS and CL for the EEG-EMG PLV and 
EEG-EMG coherence, respectively, is shown by the black lines within their respective graph. 
The EEG electrode used to determine the waveforms is displayed on the right side of each 
graph, and the corresponding EMG electrode was selected according to the procedure 
discussed in Section 3.1.3.1. 
Figure 3-7a shows that the EEG-EMG coherence waveform had a greater peak during the first 
part of the fatigue stage compared to the second part of the fatigue stage.  
In Figure 3-7b, it is observed that the EEG-EMG PLV waveform had a greater peak during the 
first compared to the second part of the fatigue stage. However, this varied between 
participants (see Appendix I3 for EEG-EMG PLV and EEG-EMG coherence waveforms for all 15 
participants)  








0 10 20 30 40 50
0.1











3.2 Quantitative results 
Section 3.2 contains the results of the statistical comparisons of the neurophysiological 
variables, which were noted in Section 3.1. All data are represented as (means (M) ± standard 
deviation (SD)), and significance of a factor conforms to p < 0.05. 
 
3.2.1 Muscle fatigue influence on force, EMG and EEG pre- and post-fatigue 
Section 3.2.1 follows from Section 3.1.2 and provides the quantitative statistics as mentioned in 
Section 2.2.7 for all 15 participants in Table 3-1 (see Appendix J.1 for box plots and normality 
tests). 
Table 3-1 : Group data for muscle fatigue influences on force, EMG and EEG measurements 





(Mean ± SD) 
post-fatigue 
(Mean ± SD) 
p value 
forceCV increased 3.473 ± 2.269 % 7.873 ± 5.568 % p = 0.001 
normalised 
beta forcePSD 
increased 0.004 ± 0.001   0.005 ± 0.001 p = 0.014 
normalised 
EMGRMS 
increased 0.037 ± 0.022 0.051 ± 0.033 p = 0.017 
EMGMPF decreased 100.589 ± 17.366 Hz 86.948 ± 19.814 Hz p = 0.001 
normalised 
beta EEGRMS 






3.2.2 Corticomuscular coupling measures pre- and post-fatigue 
Section 3.2.2 follows Section 3.1.3.3 and provides the quantitative statistics as mentioned in 
Section 2.3.6 for all 15 participants in Table 3-2 (see Appendix J.2 for box plots and normality 
tests). 





(M ± SD) 
post-fatigue 









no change 26.967± 6.399  24.33 ± 7.459 Hz p = 0.195 
beta EEG-EMG 
PLVPEAK AMP 
increased 0.102 ± 0.014   0.125 ± 0.029 p = 0.011 
beta EEG-EMG 
PLVPEAK FREQ 







3.2.3 Measures during the first and second part of the fatigue stage 
Section 3.2.3 follows from Section 3.1.3.4 and provides the quantitative statistics, as mentioned 
in Section 2.3.7, for all 15 participants in Table 3-3 (see Appendix J.3 for box plots and normality 
tests). 
Table 3-3: Group data for measurements during the first and second part of the fatigue stage 
Measurement Comparison 
from first to 
second part 
of the fatigue 
stage 
first part of the 
fatigue stage  
(Mean ± SD) 
second part of 
the fatigue stage  











0.089 ± 0.061   0.095 ± 0.055 p = 0.135 
beta EEG-EMG 
coherence PEAK AMP  
 









3.3 Summary of results presented 
Table 3-4 and Table 3-5 presents a summary of results shown in Section 3.  
Table 3-4: Summary of results presented for the present study compared to previous studies 
for pre- and post-fatigue. 
Measurement 
Comparisons between pre- and post-fatigue p value 
Present 
Study 
Previous Literature Present 
Study 
forceCV increased Increased (Ushiyama et al., 2011) p = 0.001 
Normalised beta 
forcePSD 
increased Increased (Ushiyama et al., 2011) p = 0.014 
Normalised 
EMGRMS 
increased Increased (Esposito et al., 1998; Tecchio et 
al., 2006; Yang et al., 2009; Ushiyama et al., 
2011) 
p = 0.017 
EMGMPF decreased Decreased (Esposito et al., 1998; Georgakis 
et al., 2003; Barandun et al., 2009; Ushiyama 
et al., 2011) 
p = 0.001 
Normalised beta 
EEGRMS 
increased Increased  (Abdul-latif et al., 2004; Tecchio 
et al, 2006) 
p = 0.025 
Beta EEG-EMG 
coherencePEAK AMP 
increased Contradictory (Tecchio et al., 2006; Yang et 
al., 2009, 2010; Ushiyama et al., 2011) 
p = 0.008 
Beta EEG-EMG 
coherencePEAK FREQ 
no change Does not significantly differ (Tecchio et al., 
2006; Yang et al.,2009, 2010; Ushiyama et 
al., 2011) 
p = 0.195 
Beta EEG-EMG 
PLVPEAK AMP 
increased Unknown p = 0.011 
Beta EEG-EMG 
coherencePEAK FREQ 





Table 3-5: Summary of results presented for the present study compared to previous studies 
for the first part compared to the second part of the fatigue stage. 
Measurement 









increased Increase (Al-Mulla & Sepulveda, 2010) p = 0.004 
Normalised beta 
EEGRMS 
no change Unknown p = 0.135 
Beta EEG-EMG 
coherence PEAK AMP 
decreased Contradictory (Ushiyama et al., 2011; Yang et 
al., 2009, 2010) 
p = 0.001 
Beta EEG-EMG 
PLVPEAK AMP 











The main finding for the present study is the significant increase in the beta EEG-EMG PLVPEAK 
AMP  and the beta EEG-EMG coherencePEAK AMP for the APB muscle and sensorimotor cortex from 
pre-fatigue to post-fatigue. However, during the fatigue stage, it was observed that the EEG-
EMG coherencePEAK AMP significantly decreased for the second part of the fatigue stage, whilst 
the PLV did not.  
Since both the beta EEG-EMG PLVPEAK AMP and the beta EEG-EMG coherencePEAK AMP increased, it 
could be argued that the change in amplitude from the EMG and/or the EEG, due to fatigue, 
does not confound the corticomuscular coupling result in pre- and post-fatigue; thus, the EEG-
EMG coherence findings appear directly related to the genuine phase synchronisation changes. 
However, for both the first and second part of the during fatigue stage the beta EEG-EMG 
PLVPEAK AMP and the beta EEG-EMG coherencePEAK AMP provided different results, suggesting that 
during the fatigue stage EEG and EMG amplitude co-variations confound the corticomuscular 
coupling results. The amplitude co-variations are further supported by the significant increase 
in EMG amplitude from the first to second part of the fatigue stage.  
We further discuss the influence of muscle fatigue on the force, EMG and EEG in Section 4.1, 
while Section 4.2 discusses the influence that muscle fatigue had on corticomuscular coupling. 
Section 4.3 explores other possible factors, which could influence corticomuscular coupling 
during muscle fatigue.   
4.1 Muscle fatigue influence on force, EMG and EEG  
The forceCV increased significantly from pre-fatigue to post-fatigue, which indicated attenuated 
muscle force steadiness post-fatigue. In addition, the normalised beta forcePSD significantly 
increased post-fatigue as compared to pre-fatigue. This was also shown by Ushiyama et al. 
(2011), who suggested that an increase in normalised beta forcePSD is the sensorimotor cortex’s 
attempt to maintain a stable force by discharging EMG into the beta band. This subsequently 
gets mimicked in the beta component force driven by the muscle. 
In addition, the normalised EMGRMS increased significantly from pre-fatigue to post-fatigue, 
which was also shown in previous studies (Esposito et al., 1998; Ushiyama et al., 2011). This 
suggests that the muscle attempts to maintain a stable force by recruiting additional motor 
units and/or increasing the motor unit firing frequency. 
66 
 
The EMGMPF significantly decreased from pre-fatigue to post-fatigue. This decrease was also 
observed in a fatigue study done by Barandun et al. (2009) involving the APB muscle, as well as 
in other studies for different muscles including biceps brachii, vastus medialis, vastus lateralis, 
rectus femoris and tibilias anterior (Esposito et al., 1998; Georgakis et al., 2003; Ushiyama et 
al., 2011). A decrease in the EMGMPF suggests an attenuation of the conduction velocity of the 
action potentials, changes of the motor unit action potential shape and/or the firing rate of 
motor units (Eberstein & Beattie, 1985; Moritani et al., 1986; Arendt-Nielsen et al., 1989; 
Merletti & Lo Conte, 1997), suggesting muscle fatigue. 
The normalised beta EEGRMS significantly increased from pre-fatigue to post-fatigue in the 
contra-lateral sensorimotor cortex. This was observed in a previous fatigue study, and it was 
suggested that an increase in energy was needed by the contra-lateral sensorimotor cortex in 
order to maintain a stable force (Abdul-latif et al., 2004).  
It was also noted that during the fatigue stage (Table 3-5) the beta EEGRMS decreased (i.e., in 
the contra-lateral sensorimotor region).  This decrease in the EEG beta power toward the end 
of the fatigue stage was also observed in Yang et al. (2010) during a fatigue stage of a finger 
muscle (flexor digitorum superficialis). Engel and Fries (2010) have suggested that the EEG 
within the beta band expresses more strongly if ‘status quo’ is intended (i.e., remain in its 
current state [in this study, palmar abduct was at 30% of MVC]). Thus, a decrease in EEG power 
in the beta band could suggest the inability to remain in one state or the need to change state 
in order to avoid damage to the muscle.   
These specific findings are not novel, but match the reported influence of muscle fatigue on 
force, EMG and EEG from previous studies. Therefore, they provide validation that the 
experimental protocol in this study is in accordance to previous literature. 
4.2 Corticomuscular coupling measures 
The present study showed that both the beta EEG-EMG coherencePEAK AMP and the beta PLVPEAK 
AMP increased significantly from pre-fatigue to post-fatigue.  This result is similar to the findings 
published by Tecchio et al. (2006) and Ushiyama et al. (2011). However, the other possibility is 
that during the actual fatigue stage, a different phenomenon could be observed for the 
corticomuscular coupling (similar to Yang et al., 2009, and Yang et al., 2010) as opposed to pre- 
and post- fatigue stages. It was found that the beta EEG-EMG coherencePEAK AMP decreased, 
while the beta EEG-EMG PLVPEAK AMP did not significantly change from the first to the second 
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part of the fatigue stage. The normalised beta EMGRMS significantly increased, whilst the 
normalised beta EEGRMS did not significantly change from the first to the second part of the 
fatigue stage. Therefore confirming EMG amplitude confound on corticomuscular coupling 
during fatigue.  
This decrease in the corticomuscular coupling using coherence during the fatigue stage 
matches the findings of Yang et al. (2009) and Yang et al. (2010). But based on the 
corresponding no-significant change in beta PLVPEAK AMP, this suggests that the EEG-EMG 
coherence changes during the fatigue stage are due to amplitude coherence as opposed to 
phase synchrony and that pre- and post-fatigue changes are due to phase synchrony as 
opposed to amplitude coherence. Thus, if the phase relationship of corticomuscular coupling 
needs to be measured, PLV would be the preferred measure as opposed to coherence, 
particularly during a fatiguing stage.    
Section 4.2.1 discusses corticomuscular coupling found within participants pre- and post-
fatigue while Section 4.2.2 discusses the confounding effect of amplitude during the fatigue 
stage.  
4.2.1 Corticomuscular coupling measures pre- and post-fatigue  
From Appendix H1, it was observed that out of the 15 participants, four participants showed a 
beta EEG-EMG coherencePEAK AMP decrease post-fatigue as compared to pre-fatigue. The beta 
EEG-EMG PLVPEAK AMP, shown in Appendix H2, agreed with the EEG-EMG coherence for three out 
of four participants, but did not agree for participant 2 (whose beta EEG-EMG PLVPEAK AMP 
increased post-fatigue, as compared to pre-fatigue, and whose beta EEG-EMG coherencePEAK 
AMP decreased post-fatigue, as compared to pre-fatigue).  
Appendix H3 illustrates the waveforms for EEG-EMG coherence and EEG-EMG PLV. The 
waveforms during pre-fatigue for participant 2 showed two EEG-EMG coherence and EEG-EMG 
PLV peaks, one at 28 Hz and the other at 18 Hz.  For the EEG-EMG coherence waveform, the 
EEG-EMG coherence peak, which was around 18 Hz, had a greater pre-fatigue EEG-EMG 
coherence peak, as compared to the post-fatigue EEG-EMG coherence peak. Conversely, at the 
same frequency (18 Hz) the EEG-EMG PLV waveform pre-fatigue showed an EEG-EMG PLV peak 
that was smaller than the post-fatigue EEG-EMG PLV peak. While PLV is only phase-dependent, 
coherence is both amplitude- and phase-dependent and would suggest that, during the pre-
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fatigue stage there was an increase in amplitude coherence at 18 Hz between EMG and EEG, 
which ultimately increased the EEG-EMG coherence.  
Therefore, even if the group data suggests that EEG-EMG coherence follows the phase 
relationship both pre- and post- fatigue, there are instances where amplitude coherence could 
play a role. 
4.2.2 Corticomuscular coupling measures during fatigue 
Furthermore, during the fatigue stage it was found that when the EMG amplitude increased 
compared to when the EMG amplitude had no change (see Figure 3-6a), the EEG-EMG 
coherence was smaller (see Figure 3-6f). However, notably, the EEG-EMG PLV (see Figure 3-6g) 
values remained constant (this effect of amplitude variation on coherence was simulated in 
Appendix A). 
 Ushiyama et al. (2011) reported progressive time course changes for a typical participant’s 
EEG-EMG coherence (see Figure 4-1) and observed a similar change (i.e., when EMG amplitude 
increased compared to when EMG amplitude had no change, EEG-EMG coherence was 
smaller). The only difference between the present study (and possibly that of Yang et al., 2009) 
compared to Ushiyama et al.’s (2011) study was the transition to fatigue time at which the 
EMG amplitude increased. This time point can vary depending on the muscle selection, %MVC 
and synergistic muscles (mentioned in Section 4.3.1).   
Thus, for a corticomuscular coupling study where EMG and/or EEG amplitude fluctuates and 






Figure 4-1: Adopted from Ushiyama et al. (2011) showing a ‘typical example of progressive 
changes in EMG RMS, EMG MPF, Force CV, and EEG-EMG coherence during sustained isometric 
contraction of the tibialis anterior muscle at 50% of MVC until the limit of fatigue. EMG RMS, 
EMG MPF, Force CV, and EEG-EMG coherence was calculated by sliding the 10-second window 
along the signal in 1 second steps. As for the time-frequency map of EEG-EMG coherence, the 
monochrome bar represents the magnitude of EEG-EMG coherence.’ 
Significant gamma (3550 Hz) corticomuscular coupling was also found within few participants 
during the fatigue stage. Gamma corticomuscular coupling has been observed in previous 
corticomuscular coupling fatigue studies (Tecchio et al., 2006 and Yang et al., 2009, 2010) and 
suggested to play a function role in regulating the motor performance during strong (Brown, 
2000) and dynamic contractions (Omlor et al. ,2007). This may suggest that during the fatigue 
stage, dynamic and strong voluntary contractions may be required to sustain the required 
force.  
4.3 Potential factors related to phase synchrony and/or fatigue 
Various other factors other than the EEG and EMG amplitude can confound the 
corticomuscular coupling measures, which are explored further in Section 4.3. 
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4.3.1 Synergistic muscles 
When performing a movement in which the major agonist muscle is unable to sustain the 
force, it is possible that the synergistic muscles increase activity in order to maintain the 
required force. 
Yang et al. (2009) showed a significant decrease in the EEG-EMG coherence (for brachii bicep, 
brachioradialis and triceps brachii muscle) while performing an isometric elbow contraction. 
However, Ushiyama et al. (2011) argued based on the earlier findings of Kawakami et al. (1994) 
that several synergistic muscles contributed to the generation of elbow flexion force (biceps 
brachii, 34%; brachialis, 47%; and brachioradialis, 19%). Thus, in the study by Yang et al. (2009), 
it is possible that the sustained force was compensated by the synergistic muscles (Ushiyama et 
al., 2011) and in particular the brachialis whose EEG-EMG coherence was not measured by 
Yang et al (2009). In Ushiyama et al.’s (2011) study, the tibilias anterior accounted for 
approximately 60% of the PCSA (physiological cross-sectional area) of the total dorsiflexors 
and, therefore, was regarded by him as a major agonist muscle for dorsiflexion.  
The APB muscle was chosen for our study, as it was found to be most active during a palmar 
abduction (van Oudenaarde & Oostendorp, 1995). However, the position of the forearm and 
hand was not considered for our study. Brandsma et al. (1996) observed that during a palmar 
abduction, when the forearm is supinated and the hand is in the neutral position, the APB 
muscle has smaller mean EMG activity compared to the superficial and deep abductor pollicis 
longus. In this present study, during palmar abduction, the forearm and hand were kept in a 
neutral position. As a result, the confounding effect of synergistic muscles, such as the 
superficial and deep abductor pollicis longus could still have had an influence in this study. In 
this study, the APB EEG-EMG coherence increased post-fatigue as compared to pre-fatigue but 
the EEG-EMG coherence of the synergistic muscles was not tested. Therefore there is still some 
uncertainty about the EEG-EMG coherence for the synergists and antagonists before and after 




4.3.2 Muscles of different fibre composition and function 
Since all five experiments (Tecchio et al., 2006; Yang et al., 2009, 2010; Ushiyama et al., 2011; 
and this study) used different muscles, it is possible that there are different muscle-specific 
processes, in which case the individual findings may not be generalisable. Furthermore, in 
corticomuscular coupling studies, ideally the EMG and corticomuscular coupling of all 
synergists and antagonists should be monitored in addition to that of the main agonist. 
One such muscle-specific process possibly suggested by studies, was that in order to sustain a 
force, an increase or decrease in motor neuron firing plays a more prominent role in the APB 
and tibialis anterior, while an increase or decrease in the number of motor units plays a more 
prominent role within the biceps brachii (Kukulka & Clamann, 1981; Seki & Narusawa, 1996; 
Van Cutsem et al., 1998).   
This could imply that the sensorimotor cortex would have to enhance the corticomuscular 
coupling to the APB muscle and tibialis anterior when compared to the biceps brachii in order 
to maintain a higher rate of discharge of motor units to sustain the force. Thus, this muscle-
specific process could also be the reason for the difference between Ushiyama et al.’s (2011) 
study using the tibialis anterior muscle and the present study using APB muscle to Yang et al.’s 
(2009) study using the biceps brachii. In this case, the apparent contradictory corticomuscular 
coupling results of Yang et al. (2009) may still be valid, but differences may be the result of 
muscle-specificity.  
4.3.3 Influence of EMG electrode placement on corticomuscular coupling measures 
The present study has observed that the pre- and post-fatigue result for both the EEG-EMG 
coherence and the PLV may vary if the IZ is not determined (see Appendix J). Mesin et al. 
(2009) revealed that placing electrodes without identifying the IZ can cause variations in the 
amplitude and frequency of the EMG signal.  Also, Barandun et al. (2009) observed that when 
the electrode location was further away from the IZ the mean frequency was lower. This could 
also explain the varying changes found in the corticomuscular coupling in previous studies, 
because the IZ was not considered (Ushiyama et al., 2011 ;Yang et al., 2009, 2010). Hence, the 
IZ should be taken into account for corticomuscular coupling measures.  
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4.3.4 Isometric and dynamic contractions observed different forms of fatigue 
Another notable difference is that the four experiments (Tecchio et al., 2006; Yang et al., 2009; 
Ushiyama et al., 2011 and this study) performed isometric contractions, while the fifth, Yang et 
al. (2010) performed dynamic contractions. 
Central fatigue forms a larger proportion of attenuated force generation when muscle fatigue is 
induced by an isometric contraction compared to repetitive MVC dynamic contractions 
(Søgaard et al., 2006). Therefore, another possible reason for the contradictory results during 
the fatigue stage could be due to different proportions of induced central fatigue as suggested 










This study provides evidence that after muscle fatigue occurs during a sustained isometric 
submaximal contraction, the corticomuscular coupling in the beta band between the contra-
lateral sensorimotor cortex and APB muscle increases significantly, without the confounding 
effect of amplitude. This suggests that the amplitude changes in the EEG of the sensorimotor 
cortex and in the EMG of the APB muscle do not affect the conclusions regarding the central 
nervous system monitoring, either pre- or post-fatigue. This implies an increase in the central 
nervous system monitoring of muscle activity, post-fatigue. However, during an actual fatiguing 
contraction, coherence and PLV measures of corticomuscular coupling provide different 
results, because of the confounding effect of amplitude on the corticomuscular coupling. In 
such experiments, PLV provides a more reliable measure, resulting in a physiological conclusion 
that there is no change in corticomuscular phase coupling during a fatiguing contraction.  
Whilst the present study is consistent with the confounded findings of Ushiyama et al. (2011) 
and possibly Yang et al. (2009) for the tibialis anterior muscle and bicep brachii muscle 
respectively, it is important to note that muscle-specific effects have not been experimentally 
accounted for. Therefore, these findings are not necessarily generalisable to all muscles 
without additional experimental and analytical studies. 
5.1 Further research 
Section 5.1 provides further research to be done. 
5.1.1 PLV on larger muscles pre- and post-fatigue 
The present study showed that the confounding effect of amplitude between the contracting 
muscle and sensorimotor cortex does not significantly alter the conclusions regarding the 
central nervous system monitoring of muscular fatigue in the APB muscle. 
However the APB muscle is small muscle required to do only small movements, thus suggesting 
that amplitude co-variations would be small. However larger muscles could provide higher 
amplitude co-variations, therefore PLV may still be a useful measure pre- and post-fatigue in 
larger muscles.    
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5.1.2 Observation synergist and antagonist muscles during muscle fatigue 
As mention in Section 4.3, Yang et al.’s (2009) study observed a decrease in the EEG-EMG 
coherence from pre- to post-fatigue whereas this study and Ushiyama et al. (2011) study 
observed an increase. The reason for the difference in the findings as suggested by Ushiyama et 
al. (2011) was that the main agonist muscle was not observed in Yang et al.’s (2009) study.  
Thus, a study measuring the corticomuscular coupling between all synergist and antagonist 
muscles in addition to the agonist, during muscle fatigue would prove valuable. This would 
provide a further physiological understanding of how corticomuscular coupling maintains a 
stable force output.   
5.1.3 High–resolution EMG studies during corticomuscular coupling 
In the present study, it was shown that the identification of the IZ can change the outcome of 
corticomuscular coupling measures using coherence or PLV (see Section 4.3.4). Therefore, the 
method of measuring high-resolution EMG would allow for the identification of IZs and possibly 
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Appendix A SIMULATED AND SAMPLE DATA FOR PHASE 
LOCK VALUE (PLV) VS. COHERENCE 
 
A.1 Simulated Data 
Studies have shown that coherence is dependent on both phase and amplitude (Lachaux et al., 
1999; Srinath & Ray, 2014), while PLV is only dependent on phase. 
To prove this was, in fact, the case, the author generated three cases. 
A.1.1 Both signals have a phase lock at 30 Hz with noise. 
A.1.2. Both signals have a phase lock at 30 Hz, but one signal has a random increasing 
amplitude gain. 
A.1.3 Both signals have a phase lock at 30 Hz, but one signal has a random decreasing 
amplitude gain. 
    
These cases are presented below:  
A.1.1 No Noise 
The two signal 𝑠𝑥(𝑡) and 𝑠𝑦(𝑡) are generated with a phase lock at 30 Hz and shown in Figure 
A-1: 
𝑠𝑥(𝑡) = cos(2𝜋 ∗ 5𝑡) + sin(2𝜋 ∗ 50𝑡) + sin(2𝜋 ∗ 30(𝑡 + 2))  
𝑠𝑦(𝑡) = cos(2𝜋 ∗ 30(𝑡 + 2)) + sin(2𝜋 ∗ 20𝑡) + sin(2𝜋 ∗ 10𝑡) 
Coherence and PLV (refer to Section 2.3.4 and Section 2.3.5) were then applied to 𝑠𝑥(𝑡) 
and 𝑠𝑦(𝑡) to show that both measures show a phase lock at 30 Hz (shown in Figure A-2 and 
Figure A-3). 
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Figure A-1: Section of the two signals 𝒔𝒙(𝒕) 
and 𝒔𝒚(𝒕) in blue and red, respectively. The 
signals are phase lock at 30 Hz with no noise 
added. 
 
Figure A-2: Coherence amplitude vs. 
frequency when applied to simulated signals 
𝒔𝒙(𝒕) and 𝒔𝒚(𝒕) with a phase lock at 30 Hz. 
There is a clear peak at 30 Hz. The waveform 
in blue is EEG-EMG coherence and the 




Figure A-3: PLV amplitude vs. frequency when 
applied to simulated signals 𝒔𝒙(𝒕) 
and 𝒔𝒚(𝒕) with a phase lock at 30 Hz. There is 
a clear peak at 30 Hz. The waveform in blue is 
PLV, and the waveform in red is the 95% 
confidence level (PLS). 
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A.1.2 Increasing Gain  
The two signals 𝑠𝑥(𝑡) and 𝑠𝑦(𝑡) are generated with a phase lock at 30 Hz, but a random 
increasing gain  ( ζ(t)) was added to the amplitude of  𝑠𝑦(𝑡) 
𝑠𝑥(𝑡) = cos(2𝜋 ∗ 5𝑡) + sin(2𝜋 ∗ 50𝑡) + sin(2𝜋 ∗ 30(𝑡 + 2))  
𝑠𝑦(𝑡) = ( ζ(t)) ∗ t ∗ cos(2𝜋 ∗ 30(𝑡 + 2))
+ ( ζ(t)) ∗ t ∗ sin(2𝜋 ∗ 20𝑡) + ( ζ(t)) ∗ t ∗ sin(2𝜋 ∗ 10𝑡)  
 
Coherence and PLV (refer to Section 2.3.4 and Section 2.3.5) were then applied to 𝑠𝑥(𝑡) 
and 𝑠𝑦(𝑡) to demonstrate that both measures show a phase lock at 30 Hz (shown in Figure A-5 
and Figure A-6). 
 
Figure A-4: Section of the two signals 𝒔𝒙(𝒕) 
and 𝒔𝒚(𝒕) in blue and red, respectively. The 
signals are phase lock at 30 Hz with a 
random increasing gain on 𝒔𝒚(𝒕).  
 
Figure A-5: Coherence amplitude vs. 
frequency when applied to simulated signals 
𝒔𝒙(𝒕) and 𝒔𝒚(𝒕) with a phase lock at 30 Hz. 
There is a clear peak at 30 Hz. The waveform 
in blue is EEG-EMG coherence, and the 
waveform in red is the 95% confidence level 
(CL). 
 

































- 4 - 
 
 
Figure A-6: PLV amplitude vs. frequency 
when applied to simulated signals 𝒔𝒙(𝒕) 
and 𝒔𝒚(𝒕) with a phase lock at 30 Hz. There 
is a clear peak at 30 Hz. The waveform in 
blue is PLV, and the waveform in red is the 
95% confidence level (PLS). 
 
From this, we can observe that both the PLV and coherence provide an accurate phase lock at 
30 Hz, but the coherence seems to have decreased from an amplitude of 1 to an amplitude of 
0.7, while the PLV remains with a peak of 1 at 30 Hz. Thus, the PLV is more amplitude noise 
robust compared to coherence.  
A.1.3 Decreasing Gain  
The two signals 𝑠𝑥(𝑡) and 𝑠𝑦(𝑡) are generated with a phase lock at 30 Hz, but a random 
decreasing gain  ( ζ(t)) was added to the amplitude of  𝑠𝑦(𝑡) 
𝑠𝑥(𝑡) = cos(2𝜋 ∗ 5𝑡) + sin(2𝜋 ∗ 50𝑡) + sin(2𝜋 ∗ 30(𝑡 + 2))  
𝑠𝑦(𝑡) = ( ζ(t)) ∗
1
t
∗ cos(2𝜋 ∗ 30(𝑡 + 2)) 
+ ( ζ(t)) ∗
1
t
∗ sin(2𝜋 ∗ 20𝑡) + ( ζ(t)) ∗
1
t
∗ sin(2𝜋 ∗ 10𝑡)  
 
Coherence and PLV (refer to Section 3.6.10 and Section2.3.5) were then applied to 𝑠𝑥(𝑡) 
and 𝑠𝑦(𝑡) to demonstrate that both measures show a phase lock at 30 Hz (shown in Figure A-8 
and Figure A-9). 
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Figure A-7: Section of the two signals 𝒔𝒙(𝒕) 
and 𝒔𝒚(𝒕) in blue and red, respectively. The 
signals are phase lock at 30 Hz with a 
random decreasing gain applied to 𝒔𝒚(𝒕). 
 
Figure A-8: Coherence amplitude vs. 
frequency when applied to simulated signals 
𝒔𝒙(𝒕) and 𝒔𝒚(𝒕) with a phase lock at 30 Hz. 
There is a clear peak at 30 Hz. The waveform 
in blue is EEG-EMG coherence, and the 




Figure A-9: PLV amplitude vs. frequency 
when applied to simulated signals 𝒔𝒙(𝒕) 
and 𝒔𝒚(𝒕) with a phase lock at 30 Hz. There 
is a clear peak at 30 Hz. The waveform in 
blue is EEG-EMG coherence, and the 
waveform in red is the 95% confidence level 
(PLS). 
 
From this, we can observe that both the PLV and coherence provide an accurate phase lock at 
30 Hz, but the coherence seems to have decreased from an amplitude of 1 to an amplitude of 
0.3, while the PLV remains with a peak of 1 at 30 Hz. Thus, the PLV is more noise robust 
compared to coherence.  
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A.2 Sample Data 
Divekar and John's (2012) study provided sample data for the present study in order to validate 
the consistency of the EEG-EMG PLV method. The sample data contained information regarding 
the EMG from the extensor carpi radialis longus and the EEG from C5, while a participant 
extended his wrist for 45 seconds.  Figure A-10 shows the EEG-EMG coherence waveform 
generated from the sample data, and Figure A-11 shows the PLV waveform generated from the 
sample data.   
 
Figure A-10: EEG-EMG coherence amplitude 
vs. frequency when applied to sample data 
signals. The sample data were the EMG from 
the extensor carpi radialis longus and the 
EEG from C5 while a participant extended his 
wrist for 45 seconds. The waveform in blue is 
the EEG-EMG coherence, and the waveform 
in red is the 95% confidence level (CL). 
 
 
Figure A-11: The EEG-EMG PLV amplitude vs. 
frequency when applied to sample data 
signals. The sample data contained EMG 
data from the extensor carpi radialis longus 
and EEG data from C5 while a participant 
extended his wrist for 45 seconds. The 
waveform in blue is EEG-EMG PLV, and the 
waveform in red is the 95% confidence level 
(PLS). 
Figure A-10 and Figure A-11 both show similar waveforms with peaks at 20 Hz. This 
corresponds to the data found in Divekar and John (2012), which reveals that EEG-EMG PLV can 
be used for EEG-EMG coherence studies.   
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Appendix B SAMPLE SIZE ESTIMATION 
Since this study is concerned with comparing PLV as a corticomuscular coupling measure to 
EEG-EMG coherence, the sample size was estimated by comparing the effect of two 
independent variables (IVs, e.g., pre-fatigue vs. post-fatigue) on dependent variables (DVs, e.g., 
EMG-EEG EEG-EMG coherence, EMG-EEG PLV), with the null hypothesis being that the IVs have 
an identical effect on each DV. In order to confirm an alternate hypothesis (i.e., the IVs do not 
have an identical effect on each DV), the hypothesis test must have significant statistical 
power(1 − 𝛽). That is, there must be sufficient probability that the test will be able to reject a 
false null hypothesis. 𝛽 is the probability of accepting a false null hypothesis (Type II error). 
Statistical power can therefore also be seen as the probability that a false null hypothesis will 
not be accepted. In order to achieve sufficient statistical power, the sample size of the test 
must be large enough to ensure that random sampling error does not influence the results or 
inaccurately represent the population. A typical value for power is 80% or 𝛽 = 0.2 (Motulsky, 
1995). 
The test result is said to be statistically significant if the p-value is below a certain significance 
level (𝛼), where 𝛼 is the probability of an accepting a false alternative hypothesis (Type I error). 
The lower the p-value, the less likely that the null hypothesis is true, and thus, the more 
significant the result is. A typical value for the significance level is 5% or 𝛼 = 0.05 (Motulsky, 
1995). 
This study aims to detect a significant difference in the EEG-EMG coherence and PLV peak 
amplitude in participants before and after fatigue. During the hypothesis testing, when 
comparing two means (EEG-EMG coherence or PLV peak amplitude pre- and post-fatigue), the 







where SD is the standard deviation, (𝑧𝛼 + 𝑧𝛽)
2 is the power index and ∆ is the minimum 
distance between population means that is detected as significant. Using a one-tailed 
distribution and choosing typical values of 𝛼 = 0.05 and 𝛽 = 0.2, the power index (𝑧𝛼 + 𝑧𝛽)
2  
is found to be 6.2, as noted in Table 22.1 in Motulsky (1995).  
The standard deviation and mean difference for this study was adopted from a similar study 
(Ushiyama et al., 2011) for pre- and post-fatigue coherence where  𝑆𝐷 ≈ 0.5  and ∆≈ 0.5.  
From Equation B-1, the appropriate sample size is 12.4 (𝑁 ≈ 13). Thus, in this study, 15 
participants were used to ensure significant statistical power.   
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Appendix C SUBJECT CONSENT FORM  
Definitions: 
Electrodes: Small metal caps placed on the skin to measure bio-electrical signals. 
Surface Electromyography (EMG): Study of bio-electrical signals which can be measured with 
electrodes on the skin surface near a muscle and which represent the muscle’s activity. 
Electroencephalography (EEG): Study of bio-electrical signals which can be measured on the 
scalp by electrodes and which are representative of cortical activity. 
 
Figure C-1: High-resolution EEG cap (left), EMG recording from muscles (right). 
Informed Consent 
Researchers at the Medical Research Center (MRC) /University of Cape Town (UCT) Medical 
Imaging Research Unit are developing an accurate method of determining muscle fatigue using 
EMG and EEG. Brain and muscle function would be measured by recording EEG and EMG 
waveforms from participants whilst they are required to perform a fatiguing contraction. Both 
EEG and EMG are safe, non-invasive recording techniques that require the placement of 
electrodes on the head of a participant for EEG, and the placement of electrodes on the palm 
of the hand for EMG. Each test will last approximately 1 hour, and 15 participants are required 
for the trial. 
Testing Procedure 
All testing will be carried out at the UCT Faculty of Health Sciences and has been pre-approved 
by the Human Ethics Committee. You will be required to wash your hair with shampoo prior to 
testing. For good electrical conductivity, the skin above the palm of your hand will be abraded 
and cleaned with alcohol; this causes miniscule discomfort, if any. Electrodes will be covered 
with conducting gel; this causes no discomfort.  You will be seated in a chair facing a computer 
monitor and will be fitted with a 16-channel EEG cap (see Figure 1, left) and EMG electrodes on 
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the palm of your hand (similar to Figure 1, right). A series of instructions for movements will be 
presented on a computer screen. The movements will require you to abduct your thumb and 
try to maintain it at a particular force until task failure. There will be no direct benefit to you, 
but the results of the research will be used to further the understanding of muscle fatigue. The 
trial is voluntary, and you may refuse to participate or withdraw from the trial, at any time, 
without penalty or loss of benefits to which you are otherwise entitled. 
Possible Risks Associated with Participation 
The EEG and EMG equipment is inherently safe. Temporary mild skin sensitivity may result 
from the conducting gel. In the unlikely case that you experience discomfort, you should alert 
the investigator. UCT has a public liability cover (a no-fault insurance policy) should some 
unforeseen event occur whilst you are participating in this study. 
UCT No-Fault Insurance Policy 
UCT undertakes that, in the event of your suffering any significant deterioration in health or 
well-being, from any unexpected sensitivity or toxicity, that is caused by your participation in 
the study, it will provide immediate medical care. UCT has appropriate insurance cover to 
provide prompt payment of compensation for any trial-related injury, according to the 
guidelines outlined by the Association of the British Pharmaceutical Industry (ABPI, 1991). 
Broadly speaking, the ABPI guidelines recommend that the insured organisation (UCT), without 
legal commitment, should compensate you without your having to prove that UCT is at fault. 
An injury is considered trial-related if, and to the extent that, it is caused by study activities. 
You must notify the study doctor immediately of any side effects and/or injuries during the 
trial, whether they are research-related or other related complications. 
UCT reserves the right not to provide compensation if, and to the extent that, your injury came 
about because you chose not to follow the instructions that you were given while you were 
taking part in the study. Your right in law to claim compensation for injury where you prove 
negligence is not affected. Copies of these guidelines are available on request. 
Statement of Understanding and Consent 
I confirm that I am over 18 years of age and that the exact procedure and techniques and the 
possible complications of the above tests have been thoroughly explained to me. I am free to 
withdraw from the study at any time should I choose to do so. I understand that I may not go 
through with the testing procedure if I suffer from any kind of neuromuscular or muscular 
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disorder and may ask questions at any time during the testing procedure. I know that the 
personal information required by the researchers and derived from the testing procedure will 
remain strictly confidential and will only be revealed as a number in classification analysis. I 
have carefully read this form and understand the nature, purpose and procedures of this study. 
I agree to participate in this research project conducted by the MRC/UCT Medical Imaging 
Research Unit. 
Subject Information Sheet 
Name of volunteer / guardian (if necessary):_______________________________________ 
Signature:___________________________________________________________________ 




Principal Investigator:                        Dr LR John (Lecturer, UCT)  
Co-Investigators:          Mr J Joseph (MSc (Med) (BME) student, UCT) 
   
Contact details:    
Principal Investigator contact: 
Lester John, BScEng, PhD 
Electronic & Biomedical Engineer  
MRC/UCT Medical Imaging Research Unit 
Department of Human Biology 
Faculty of Health Sciences 
University of Cape Town  
Observatory 7925 
South Africa 
Tel: +27 21 406-6548 
Fax: +27 21 448-7226 
Lester.John@uct.ac.za  
Research Ethics Committee contact: 
Mrs Lamees Emjedi 
Research Ethics Committee 
E 52 Room 24, Old Main Building, Groote 
Schuur Hospital, Observatory 
Telephone:  27 21 406 6338 
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Appendix D STRAIN GAUGE AMPLIFIER DATASHEET 
RS Components, Stock no. 435-692 
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Appendix E DATA ACQUISITION   
The following section further explains how the user interface application was generating in 
LABVIEW. 
Figure E-1 shows the switches used to activate the different sections of the experiment. The 
participants had 17 stages to complete.  
 Eyes closed and eyes open: Two stages of eyes open and eyes closed, 
where the participant just relaxed.  
 Pre-fatigue stage: Six stages of pressing the thumb at 10% of MVC for 10 
seconds.  
 Fatigue stage: One stage of pressing the thumb at 30% of MVC until task 
failure.  
 Post-fatigue Stage: Six stages of pressing this thumb at 10% of MVC for 
10 seconds. 
 Eyes closed and eyes open: Two stages of eyes open and eyes closed, 
where the participant just relaxed.  
The switches controlled the recording of data. They were only activated by the 
invigilator, once the participant reached his targeted %MVC, and were then deactivated when 
each stage was completed.  
Each stage, except for the fatigue stage, was deactivated using ‘if’ statements as shown in 
Figure E-2 and Figure E-3. The switches were checked every 100 milliseconds. 
Figure E-1: Start/stop 
switches for the 
experiment 
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Figure E-2: If statement to deactivate pre- and post-fatigue stages after 10 seconds. 
 
Figure E-3: If statement to deactivate eyes open and eyes closed stages after 60 seconds. 
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Figure E-4 gave the invigilator the number of stages completed as 
well as the input of the participant’s %MVC in volts. Each stage was 
incremented by 1, when a switch was deactivated. This can be seen 
in Figure E-3 and Figure E-2.  




Figure E-5: MATLAB script converting the voltage strain 
gauge value into a percentage MVC, where x is the 
current strain gauge value, i is the initial value to bring the 
strain to 0, mvc is the 100% of MVC entered by the 
invigilator, y is the current %MCV and z is the real value of 
the strain gauge. 
As shown in Figure E-6, the fatigue stage switch was deactivated, which stopped the recording 
of data, using a MATLAB script and circular buffer. The MATLAB script was used to deactivate 
recording once the participant was thought to be fatigued. A participant was considered 
fatigued when his %MCV was below 10% of the target %MVC for longer than 2 seconds.  
 
Figure E-6: LabVIEW block diagram of invigilator’s screen. Deactivation of the fatigue switch 
stopped the recording of data once the participant was below 20% of MVC for longer than 2 
seconds. The %MCV was calculated in the initial MATLAB script (refer to Figure E-5), and 2000 
samples (i.e., 2 seconds of data) were then stored in the circular buffer. Once the buffer was 
full, the data were extracted and checked to see whether the average value was below 20% of 
Figure E-4: Illustrates 
the number of stages 
completed 
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the participant’s MVC. In the diagram,  a is the array containing the 2000 samples, mvc is 100% 
of MCV of the participant entered by the invigilator and b indicates whether the participant’s 
%MVC was below 20%. The second ‘if’ statement (third block) activated the fatigue switch if 
the average was below 20%. 
The timers shown in Figure 2-12 were controlled by the switches shown in Figure E-7. Once the 
switch was deactivated, the timers would reset. These timers allowed the invigilator to view 
the amount of time that had elapsed per stage.    
 
Figure E-7: The top of the figure shows the five switches that controlled when the timers reset 
and started in addition to when data needed to be recorded into files. The data were extracted 
from the DAQ 6210 EEG for the 16-channel EEG and from the DAQ 6210 EMG for the eight-
channel EMG, two-channel EOG and one-channel strain gauge voltage. The different stages 
were saved into different files that were controlled by the switches. 
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Appendix F EMG AVERAGE INSTANTANEOUS FREQUENCY 
(AIF)  
F.1 Method 
The average instantaneous frequency (AIF) has been shown to be a more robust method for 
the EMG fatigue analysis as opposed to the EMGMNF, since it is not sensitive to different 
window sizes (Georgakis et al., 2003).  The EMGAIF was applied by the following method (refer 
to Code G-9 for MATLAB code): 








2. The instantaneous frequency 𝜔(𝑡) is estimated as the first derivative of the phase 
(implemented with first-order finite differences). 
𝜔(𝑡) = 𝜃′(𝑡) Equation F-2 
3. The instantaneous frequency values are then averaged over consecutive non-




















Figure F-1: Typical example of a participant showing progressive changes in their EMGAIF during 
sustained isometric contraction of the APB muscle at 30% of MVC until task failure. The EMGAIF 
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F.3 Statistical Analysis: EMGAIF comparisons between pre- and post-fatigue  
The EMGAIF decreased significantly from pre-fatigue to post-fatigue (116.072 ± 15.698 to 97.366 
± 15.055 Hz, p =0.000). 
Testing for assumptions, through the presence of outliers, is shown in Figure F-2, and Table F-1 
shows the testing of normality. The box plot, shown in Figure F-2, shows no outliers. Table F-1, 
which presents the results of the Shapiro-Wilk test, shows a p > 0.05, which indicates that the 












Figure F-2: Box plot of the EMGAIF between pre- and post-fatigue. Significant differences 
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Table F-1: Shapiro-Wilk test of normality for the EMGAIF pre- and post-fatigue using SPSS. 
Stage 
Shapiro-Wilk 
Statistic df Sig. 
EMGAIF Pre-fatigue .920 15 .190 
Post-fatigue .961 15 .715 
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Appendix G CODE SNIPPETS 
The following section contains code snippets used in this study for data analysis. 
Code G-1: Extract data from LabVIEW into MATLAB 
eeg_exp1 = dlmread('EEG_Pre_Fatigue.lvm','',23,0); 
emg_exp1 = dlmread('EMG_Pre_Faigue.lvm','',23,0); 
  
eeg_exp2 = dlmread('EEG_Fatigue.lvm','',23,0); 
emg_exp2 = dlmread('EMG_Fatigue.lvm','',23,0); 
  
eeg_exp3 = dlmread('EEG_Post_Fatigue.lvm','',23,0); 













Code G-2: EEG and EMG filtering 
[b,a] = butter(4,[10/500 200/500],'bandpass'); 
[f,e] = butter(4,[0.5/500 100/500],'bandpass'); 
 
for emg_elec=1:8 
    EMG_1(emg_elec,:)  = filtfilt(b,a,EMG_1(emg_elec,:) ); 
    EMG_2(emg_elec,:)  = filtfilt(b,a,EMG_2(emg_elec,:) ); 
    EMG_3(emg_elec,:)  = filtfilt(b,a,EMG_3(emg_elec,:) ); 
    EMG_1(emg_elec,:)  = filtfilt(d,c,EMG_1(emg_elec,:) ); 
    EMG_2(emg_elec,:)  = filtfilt(d,c,EMG_2(emg_elec,:) ); 




    EEG_1(eeg_elec,:)  = filtfilt(f,e,EEG_1(eeg_elec,:) ); 
    EEG_2(eeg_elec,:)  = filtfilt(f,e,EEG_2(eeg_elec,:) ); 
    EEG_3(eeg_elec,:)  = filtfilt(f,e,EEG_3(eeg_elec,:) ); 
    EEG_1(eeg_elec,:)  = filtfilt(d,c,EEG_1(eeg_elec,:) ); 
    EEG_2(eeg_elec,:)  = filtfilt(d,c,EEG_2(eeg_elec,:) ); 
    EEG_3(eeg_elec,:)  = filtfilt(d,c,EEG_3(eeg_elec,:) ); 
end; 
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Code G-4: La placian of EEG and rectification of EMG 




M = ExtractMontage('10-5-System_Mastoids_EGI129.csd',E); 







EEG_2= CSD (EEG_2, G, H,lamda,head); 
EEG_2=EEG_2'; 
  





Code G-5: Power Spectral Density 
Psd=pwelch(data,1024,0,2000,1000); 
The function consisted of five attributes: 
1. Input signal.  
2. Window size attribute/number of samples to use for each window. The smaller the 
sample size, the greater the amount of windows.  
3. Number of samples by which the sections overlapped, which was selected to be zero.  
4. FFT length, which determined the frequencies at which the coherence was estimated. 
This study chose a frequency resolution of 0.5 Hz.  
5. Sampling frequency, which was 1000 Hz.  
Code G-6: ForceCV 
force_CV=abs(std(force)/mean(force) *100; 
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Code G-8: EMGMNF 
PEMG,freq]= pwelch(emg,1024,0,2000,1000)); 
MPF=sum(PEMG.*freq)/sum(PEMG) 
The function consisted of five attributes: 
1. Input signal.  
2. Window size attribute/number of samples to use for each window. The smaller the 
sample size, the greater the amount of windows to be averaged. 
3. Number of samples by which the sections overlapped, which was selected to be zero.  
4. FFT length, which determined the frequencies at which the coherence was estimated, 
which allowed a frequency resolution of 0.5 Hz.  
5. Sampling frequency, which was 1000 Hz. 
 
Code G-9: EMGAIF 
Hx=hilbert(emg); 




Code G-10: Normalised beta force PSD 
[b,a] = butter(2,[15/500 35/500],'bandpass'); 
Force  = filtfilt(b,a, Force) 
[data, freq]=pwelch(Force,1024,0,2000,1000); 
sd_force_beta(subject,2)=sum(data(30:70).*freq(30:70))/sum(data.*freq);  
The function consisting of pwelch expected five attributes: 
1. Input signal.  
2. Window size attribute/number of samples to use for each window. The smaller the 
sample size, the greater the amount of windows. This was selected to be 1024 samples 
in order to pick up very low frequencies.  
3. Number of samples by which the sections overlapped, which was selected to be zero.  
4. FFT length, which determined the frequencies at which the coherence was estimated. 
This study chose a frequency resolution of 0.5 Hz.  
5. Sampling frequency, which was 1000 Hz.  
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Code G-11: Beta EEGRMS 
[b,a] = butter(4,[15/500 35/500],'bandpass'); 
Eeg_beta  = filtfilt(b,a,eeg(:,2:17))' 
beta_eeg_rms=(sum((eeg_beta).^2)/length(eeg_eeg_beta)).^0.5; 
 
Code G-12: Coherence between two signals 
Coh_before(eeg_elec,:)=mscohere(EEG,EMG,256,0,2000,1000); 
Each stage for each participant was a 2D matrix, which comprised the first dimension for the 
EEG channel used and the last dimension containing the EEG-EMG coherence values respective 
to their frequency. 
The function required six attributes: 
1. The first signal, which was an EEG channel.  
2. The second signal, which was the EMG channel. 
3. Window size/number of samples to use for each section. The smaller the sample size, 
the greater the amount of windows to be averaged for the EEG-EMG coherence value. 
This was selected to be 256 Hz, allowing the lowest beta band signal (i.e., 15 Hz) to be 
picked up at least three times (sampling rate 1000 Hz). 
4. Number of samples by which the sections overlapped, which was selected to be zero. 
5. FFT length, which determined the frequencies at which the coherence was estimated, 
which allowed a frequency resolution of 0.5 Hz.  
6. Sampling frequency, which was 1000 Hz.  






filtSpec.range = [lowerfreq-freqdiff upperfreq+freqdiff]; 
filtSpec.order = 200; 
filtPts = fir1(filtSpec.order, 2/srate*filtSpec.range); 
sx = filter(filtPts, 1, sx); 
sy = filter(filtPts, 1, sy); 
 




%Instantaneous Phase  
Phi_Gx = atan2(imag(Hx),sx); 
Phi_Gy = atan2(imag(Hy),sy); 
  
%% PLV  
expon_plv=(exp(1i.*(unwrap(Phi_Gx-(Phi_Gy))))); 
plv=abs(mean(expon_plv))); 
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Code G-14: Phase lock value significance between two signals 
%% PLV Sig 
parfor shift=1:100 
     
Phi_Gx_shift=circshift(Phi_Gx,[ceil(((length(sx)/100)*shift)*rand(1)) 
0]); 















for point=11:499            
temp(point)=abs((sum(data(point:500).*freq(point:500)
))-(sum(freq(10:point).*data(10:point))));                        
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Appendix H CORTICOMUSCULAR COUPLING RESULTS FOR 
ALL 15 PARTICIPANTS DURING PRE- AND POST-FATIGUE 
The following section provides the corticomuscular coupling results for all 15 participants pre- 
and post-fatigue. 
H.1 Beta EEG-EMG coherencePEAK AMP 






Decrease(  )or 
Increase( ) 
1 0.0183629717536934 0.0609836696794722  
2 0.0331842319037816 0.0312433296048990  
3 0.0321651152491742 0.0202478475756662  
4 0.0157468602046451 0.0238549549400445  
5 0.0233762144459524 0.0629043567283901  
6 0.0137496300937412 0.0297720933818294  
7 0.0327403541191855 0.0397166919356443  
8 0.0236315332652836 0.0162752257284659  
9 0.0224265174473097 0.0344548758946102  
10 0.0298976727827585 0.0276243918237810  
11 0.0122452782616103 0.0156622527293475  
12 0.0293205416472235 0.0508640843044285  
13 0.0224692930070013 0.0251859879491958  
14 0.0216399718859184 0.0371458461535892  
15 0.0177939818521451 0.0406366950520167  
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H.2 Beta EEG-EMG PLV PEAK AMP 
Participant Pre-Fatigue beta EEG-
EMG PLV PEAK AMP 
Post-Fatigue beta 
EEG-EMG PLV PEAK AMP 
Decrease(  )or 
Increase( ) 
1 0.0931124706446549 0.172843327929132  
2 0.126358769308164 0.133789600211654  
3 0.117449547960637 0.0931338851179774  
4 0.109680293834906 0.110812580995039  
5 0.0908576213232329 0.181183226852361  
6 0.113626944735515 0.137949902211405  
7 0.0768013270210087 0.132532752357386  
8 0.105540755526864 0.0892700599950594  
9 0.0908117620071869 0.139186781042359  
10 0.0977317870007614 0.0765789778134839  
11 0.110706327658335 0.115211951737522  
12 0.119766324784115 0.143881462790900  
13 0.0868084186408449 0.0993445340396393  
14 0.0868503404140767 0.111693699624352  
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H.3 EEG-EMG PLV and EEG-EMG Coherence Pre- and Post-fatigue 
Waveforms 
---- CL ---pre-fatigue ----post-fatigue --- pre-fatigue significance ---post-fatigue significance 
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Appendix I CORTICOMUSCULAR COUPLING RESULTS FOR 
ALL 15 PARTICIPANTS DURING THE FIRST AND SECOND 
PART OF THE FATIGUE STAGE 
The following section provides the corticomuscular coupling results for all 15 participants 
during the first and second fatigue stage. 
I.1 beta EEG-EMG coherencePEAK AMP 
Participant First part of the 
fatigue stage beta 
EEG-EMG 
coherencePEAK AMP 
Second part of the 
fatigue stage beta 
EEG-EMG 
coherencePEAK AMP 
Decrease(  )or 
Increase( ) 
1 0.0644897469361312 0.0361004408282405  
2 0.0489997087618671 0.0334889901961487  
3 0.0396260076007534 0.0270491863364569  
4 0.0588389270528980 0.0392330773108138  
5 0.0923641140131857 0.0832587521636676  
6 0.0515979284588585 0.0367338546390713   
7 0.0570734413996620 0.0804151383008023  
8 0.0624438015702863 0.0415229241971975  
9 0.0596052123463371 0.0366588446045059  
10 0.0483457945120075 0.0347416379317567  
11 0.0688759170183508 0.0372479705412022  
12 0.0350541423500456 0.0261938015901441  
13 0.0430388682818212 0.0361477667474020  
14 0.0794176761205572 0.0515376864645929  
15 0.0779480320668481 0.0270927106470108  
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I.2 beta EEG-EMG PLV PEAK AMP 
Participant First part of the 
fatigue stage beta 
EEG-EMG PLV PEAK AMP 
Second part of the 
fatigue stage beta 
EEG-EMG PLV PEAK AMP 
Decrease(  )or 
Increase( ) 
1 0.129303855500476 0.113379173730370  
2 0.128960310418971 0.163137595566550  
3 0.138390474084314 0.122871956833493  
4 0.141463007475027 0.170013063631083  
5 0.240654256884577 0.267478811772516  
6 0.136529383933236 0.136242986513911  
7 0.143291974531524 0.210705736259326  
8 0.124084785172180 0.143676674051873  
9 0.137277588461526 0.151426593947092  
10 0.120331108051706 0.160588204259055  
11 0.158807268263484 0.153206879094984  
12 0.175515078172112 0.119185461410642  
13 0.113242152336277 0.132415176885495  
14 0.216992475238212 0.186052618754417  
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I.3 EEG-EMG PLV and EEG-EMG coherence pre- and post-fatigue 
waveforms 
---- CL ---pre-fatigue ----post-fatigue --- pre-fatigue significance ---post-fatigue significance 
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Appendix J DETAILED QUANTITATIVE RESULTS 
Appendix J contains the results of the statistical comparisons of the neurophysiological 
variables, which were noted in Section 3.1. All data are represented as (means (M) ± standard 
deviation (SD)), and significance of a factor conforms to p < 0.05. 
J.1 Muscle fatigue influence on force, EMG and EEG pre- and post-fatigue 
Section J.1 follows from Section 3.1.2 and provides the quantitative statistics as mentioned in 
Section 2.2.7 for all 15 participants for the observed measures pre- and post-fatigue: 
1. forceCV 
2. normalised beta forcePSD 
3. normalised EMGRMS  
4. EMGMPF  
5. normalised beta EEGRMS 
As mentioned in Section 2.2.7, testing for assumptions was done for each measure. The 
observation of outliers was shown in the box-plots below each measure. The tests for normality 
were shown in the tables below each measure. Box plots for all measures, showed no outliers, 
and the results of all Shapiro-Wilk tests of normality, showed a p > 0.05, indicating an 
approximate normal distribution in each respective measure. 
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J.1.1 ForceCV comparisons between pre- and post-fatigue (see also Figure 3-2d) 
The forceCV significantly increased from pre-fatigue to post-fatigue (3.473 ± 2.269 to 7.873 ± 
5.568%, p = 0.001).   











Figure J-1: Box plot of the forceCV between pre- and post-fatigue. Significant differences are 
denoted by: * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). 
Table J-1: Shapiro-Wilk test of normality for the forceCV, pre- and post-fatigue using SPSS. 
Stage 
Shapiro-Wilk 
Statistic df Sig. 
ForceCV Pre-fatigue .924 15 .221 
Post-fatigue .919 15 .187 
*** 
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J.1.2 Normalised beta forcePSD comparisons between pre- and post-fatigue (see also 
Figure 3-2e) 
The normalised beta forcePSD significantly increased from pre-fatigue to post-fatigue (0.004 ± 
0.001 to 0.005 ± 0.001, p = 0.014).  



















Figure J-2: Box plot of beta the forcePSD between pre- and post-fatigue. Significant differences 
are denoted by: * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). 




Statistic df Sig. 
Normalised beta forcePSD Pre-fatigue .973 15 .905 
Post-fatigue .951 15 .545 
* 
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J.1.3 Normalised EMGRMS comparisons between pre- and post-fatigue (see also 
Figure 3-2f) 
The normalised EMGRMS significantly increased from pre-fatigue to post-fatigue (0.037 ± 0.022 
to 0.051 ± 0.033, p = 0.017).  

















Figure J-3: Box plot of the normalised EMGRMS between pre- and post-fatigue. Significant 
differences are denoted by: * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). 




Statistic df Sig. 
Normalised EMGRMS Pre-fatigue .925 15 .233 
Post-fatigue .929 15 .266 
  
* 
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J.1.4 EMGMPF comparisons between pre- and post-fatigue (see also Figure 3-2g) 
The EMGMPF decreased significantly from pre-fatigue to post-fatigue (100.589 ± 17.366 to 
86.948 ± 19.814 Hz, p = 0.001).  











Figure J-4: Box plot of the EMGMPF between pre- and post-fatigue where ˚ (number) indicates a 
participant who is a mild outlier. Significant differences denoted by: * (p < 0.05), ** (p < 0.01) 
and *** (p < 0.001). 
Table J-4: Shapiro-Wilk test of normality for the EMGMPF pre- and post-fatigue using SPSS. 
Stage 
Shapiro-Wilk 
Statistic df Sig. 
EMGMPF  Pre-fatigue .985 15 .993 
Post-fatigue .965 15 .779 
 
*** 
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J.1.5 Normalised beta EEGRMS comparisons between pre- and post-fatigue (see also 
Figure 3-2h) 
The normalised beta EEGRMS significantly increased from pre-fatigue to post-fatigue (0.043 ± 
0.017 to 0.048 ± 0.021, p=0.025).  



















Figure J-5: Box plot of the normalised beta EEGRMS between pre- and post-fatigue. Significant 
differences are denoted by: * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). 




Statistic df Sig. 
Normalised beta EEGRMS Pre-fatigue .903 15 .106 
Post-fatigue .898 15 .090 
* 
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J.2 Corticomuscular coupling measures pre- and post-fatigue 
Section J.2 follows Section 3.1.3.3 and provides the quantitative statistics as mentioned in 
Section 2.3.6 for all 15 participants for the observed measures pre- and post-fatigue: 
1. beta EEG-EMG coherence PEAK AMP  
2. beta EEG-EMG coherence PEAK FREQ  
3. beta EEG-EMG PLVPEAK AMP 
4. beta EEG-EMG PLVPEAK FREQ 
 
As mentioned in Section 2.3.6, testing for assumptions was done for each measure. The 
observation of outliers was shown in the box-plots below each measure. The tests for normality 
were shown in the tables below each measure. Box plots for all measures, showed no outliers, 
and the results of all Shapiro-Wilk tests of normality, showed a p > 0.05, indicating an 
approximate normal distribution in each respective measure.  
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J.2.1 Beta EEG-EMG coherence PEAK AMP comparisons between pre- and post-fatigue 
(See also Figure 3-5a) 
The beta EEG-EMG coherence PEAK AMP significantly increased from pre-fatigue to post-fatigue 
(0.023 ± 0.007 to 0.034 ± 0.017, p = 0.008).   

























Figure J-6: Box plot of the beta EEG-EMG coherence PEAK AMP between pre- and post-fatigue. 
Significant differences denoted by: * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). 
Table J-6: Shapiro-Wilk test of normality for the beta EEG-EMG coherence PEAK AMP pre- and 
post-fatigue using SPSS. 
Stage 
Shapiro-Wilk 
Statistic df Sig. 
Beta EEG-EMG coherencePEAK AMP Pre-fatigue .936 15 .336 
Post-fatigue .928 15 .251 
** 
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J.2.2 Beta EEG-EMG coherence PEAK FREQ between pre- and post-fatigue (see also 
Figure 3-5a) 
The beta EEG-EMG coherence PEAK FREQ did not differ significantly from pre-fatigue to post-
fatigue (26.967± 6.399 to 24.33 ± 7.459 Hz, p = 0.195).  




























Figure J-7: Box plot of the beta EEG-EMG coherence PEAK FREQ between pre- and post-fatigue.  
Table J-7: Shapiro-Wilk test of normality for the beta EEG-EMG coherence PEAK FREQ pre- and 
post-fatigue using SPSS. 
Stage 
Shapiro-Wilk 
Statistic df Sig. 
Beta EEG-EMG coherence PEAK FREQ Pre-fatigue .936 15 .336 
Post-fatigue .928 15 .251 
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J.2.3 Beta EEG-EMG PLVPEAK AMP comparisons between pre and post fatigue (see also 
Figure 3-5b) 
The beta EEG-EMG PLVPEAK AMP significantly increased from pre-fatigue to post-fatigue (0.102 ± 
0.014 to 0.125 ± 0.029, p = 0.011).  




















Figure J-8: Box plot of the beta EEG-EMG PLVPEAK AMP between pre- and post-fatigue. Significant 
differences denoted by: * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). 




Statistic df Sig. 
Beta EEG-EMG PLVPEAK AMP Pre-fatigue .967 15 .809 
Post-fatigue .961 15 .716 
* 
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J.2.4 Beta EEG-EMG PLVPEAK FREQ between pre- and post-fatigue (see also Figure 
3-5b) 
The beta EEG-EMG PLVPEAK FREQ did not differ significantly from pre-fatigue to post-fatigue 
(23.967± 5.835 Hz to 24.8 ± 5.64 Hz, p = 0.686).  























Figure J-9: Box plot of the beta EEG-EMG PLVPEAK FREQ between pre- and post-fatigue. 
Table J-9: Shapiro-Wilk test of normality for the beta EEG-EMG PLVPEAK FREQ pre- and post-
fatigue using SPSS. 
Stage 
Shapiro-Wilk 
Statistic df Sig. 
Beta EEG-EMG PLVPEAK FREQ Pre-fatigue .922 15 .206 
Post-fatigue .974 15 .917 
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J.3 Measures during the first and second part of the fatigue stage 
Section J.3 follows from Section 3.1.3.4 and Section 3.1.3.4 and provides the quantitative 
statistics, as mentioned in Section 2.3.7, for all 15 participants for the observed measures 
during the first and second part of the fatigue stage: 
1. normalised beta EMGRMS  
2. normalised beta EEGRMS  
3. beta EEG-EMG coherence PEAK AMP  
4. beta EEG-EMG PLVPEAK AMP 
As mentioned in Section 2.3.7, testing for assumptions was done for normalised beta EMGRMS 
and normalised beta EEGRMS. The observation of outliers was shown in the box-plots below 
each measure. The tests for normality were shown in the tables below each measure. Box plots 
for all measures, showed no outliers, and the results of all Shapiro-Wilk tests of normality, 
showed a p > 0.05, indicating an approximate normal distribution in each respective measure.  
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J.3.1 Normalised beta EMGRMS comparisons during the first and second part of the 
fatigue stage (see also Figure 3-6d) 
The normalised beta EMGRMS significantly increased from the first to the second part of the 
fatigue stage (0.096 ± 0.081 to 0.122 ± 0.081, p = 0.004).  



















Figure J-10: Box plot of the normalised beta EMGRMS during the first and second part of the 
fatigue stage. Significant differences are denoted by: * (p < 0.05), ** (p < 0.01) and *** (p < 
0.001). 
Table J-10: Shapiro-Wilk test of normality for the normalised beta EMGRMS during the first and 
second part of the fatigue stage. 
Stage 
Shapiro-Wilk 
Statistic df Sig. 
Normalised beta 
EMGRMS 
first part of the fatigue stage .949 15 .511 
second part of the fatigue 
stage 
.902 15 .102 
** 
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J.3.2 Normalised beta EEGRMS comparisons during the first and second part of the 
fatigue stage (see also Figure 3-6e) 
The normalised beta EEGRMS did not differ from the first to the second part of the fatigue stage 
(0.089 ± 0.061 to 0.095 ± 0.055, p = 0.135).  



















Figure J-11: Box plot of the normalised beta EEGRMS during the first and second part of the 
fatigue stage. 
Table J-11: Shapiro-Wilk test of normality for the normalised beta EEGRMS during the first and 
second part of the fatigue stage. 
Stage 
Shapiro-Wilk 
Statistic df Sig. 
Normalised beta 
EEGRMS 
first part of the fatigue stage .915 15 .184 
second part of the fatigue 
stage 
.908 15 .149 
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J.3.3 Beta EEG-EMG coherence PEAK AMP comparisons during the first and second part 
of the fatigue stage (see also Figure 3-7a) 
The beta EEG-EMG coherencePEAK AMP significantly decreased from the first to the second part of 
the fatigue stage (0.059 ± 0.016 to 0.042 ± 0.017, p = 0.001). See Table J-12 for the non-
parametric signed test results. 
Table J-12: Non-parametric signed test of the beta EEG-EMG coherencePEAK AMP for the first part 
of the fatigue stage compared to the second part of the fatigue stage using SPSS. 







- 49 - 
 
J.3.4 Beta EEG-EMG PLV PEAK AMP comparisons during the first and second part of the 
fatigue stage (see also Figure 3-7b) 
The beta EEG-EMG PLV PEAK AMP did not differ from the first to the second part of the fatigue 
stage (0.154 ± 0.039 to 0.16 ± 0.04, p = 1.000). See Table J-13 for the non-parametric signed 
test results. 
Table J-13: Non-parametric signed test of the beta EEG-EMG PLVPEAK AMP for the first part of the 
fatigue stage compared to the second part of the fatigue stage using SPSS. 
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Appendix K CORTICOMUSCULAR COUPLING OVER 
INNERVATION ZONE AND AWAY FROM INNERVATION 
ZONE 
This section shows the vulnerability of performing EEG-EMG coherence and PLV without 
considering the IZ.   Figure K-1 is an example of a participant’s EEG-EMG coherence and PLV 
pre- and post-fatigue when choosing EMG electrodes located over the IZ and away from the IZ. 
   
Figure K-1: Pre- (blue) and post-fatigue (red) comparisons of a) EEG-EMG coherence and b) 
EEG-EMG PLV while performing a sustained isometric contraction at 10% of MVC. The 
estimated confidence level for PLV and EEG-EMG coherence is shown by the black lines within 
the respective graph.  
From Figure K-1, it is apparent that EEG-EMG coherence and PLV decrease post- fatigue 
compared to pre-fatigue over the IZ, while the contradictory result is found when placed away 
from the IZ.   
From Figure K-1a, the EEG-EMG coherence amplitude peak is also higher away from the IZ as 
denoted in an EMG-EMG coherence study done by Keenan et al. (2011). In addition, the 
increase in the EEG-EMG coherence amplitude could be attributed to the increase in the EMG 
amplitude away from the IZ.  



































  frequency (Hz) frequency (Hz) 


















- 51 - 
 
From Figure K-1b, the PLV amplitude seems to increase with an electrode placed away from the 
innervation post-fatigue and to decrease pre-fatigue. However, the PLV is not amplitude-
sensitive but is frequency-dependent; thus, the result could be attributed to the spectral 
estimates of the frequency content having been altered by electrode location relative to the IZ 
(Mesin et al., 2009). 
